Multi-network virus immunization

ABSTRACT

An apparatus, device, methods, computer program product, and system are described that determine a virus associated with a communications network, and distribute an anti-viral agent onto the communications network using a bypass network, the bypass network configured to provide transmission of the anti-viral agent with at least one of a higher transmission speed, a higher transmission reliability, a higher transmission security, and/or a physically-separate transmission path, relative to transmission of the virus on the communications network.

CROSS-REFERENCE TO RELATED APPLICATIONS

The present application is related to and/or claims the benefit of theearliest available effective filing date(s) from the following listedapplication(s) (the “Priority Applications”), if any, listed below(e.g., claims earliest available priority dates for other thanprovisional patent applications or claims benefits under 35 USC §119(e)for provisional patent applications, for any and all parent,grandparent, great-grandparent, etc. applications of the PriorityApplication(s)). In addition, the present application is related to the“Related Applications,” if any, listed below.

PRIORITY APPLICATIONS

-   -   (1) For purposes of the USPTO extra-statutory requirements, the        present application constitutes a continuation-in-part of U.S.        patent application Ser. No. 13/431,850 entitled “MULTI-NETWORK        VIRUS IMMUNIZATION”, naming Edward K.Y. Jung, Royce A. Levien,        Robert W. Lord, Mark A. Malamud, John D. Rinaldo, Jr., and        Lowell L. Wood, Jr. as inventors, filed Mar. 28, 2012, which is        currently co-pending, or is an application of which a currently        co-pending application is entitled to the benefit of the filing        date;    -   (2) For purposes of the USPTO extra-statutory requirements, the        present application constitutes a continuation-in-part of U.S.        patent application Ser. No. 11/526,213 entitled “VIRUS        IMMUNIZATION USING PRIORITIZED ROUTING”, naming Edward K.Y.        Jung, Royce A. Levien, Robert W. Lord, Mark A. Malamud, John D.        Rinaldo, Jr., and Lowell L. Wood, Jr. as inventors, filed Sep.        22, 2006, which is currently co-pending, or is an application of        which a currently co-pending application is entitled to the        benefit of the filing date;    -   (3) For purposes of the USPTO extra-statutory requirements, the        present application constitutes a continuation-in-part of U.S.        patent application Ser. No. 11/492,691 entitled “MULTI-NETWORK        VIRUS IMMUNIZATION WITH TRUST ASPECTS”, naming Edward K.Y. Jung,        Royce A. Levien, Robert W. Lord, Mark A. Malamud, John D.        Rinaldo, Jr., and Lowell L. Wood, Jr. as inventors, filed Jul.        24, 2006, now issued as U.S. Pat. No. 8,151,353;    -   (4) For purposes of the USPTO extra-statutory requirements, the        present application constitutes a continuation-in-part of U.S.        patent application Ser. No. 11/492,689 entitled “MULTI-NETWORK        VIRUS IMMUNIZATION WITH SEPARATE PHYSICAL PATH”, naming Edward        K.Y. Jung, Royce A. Levien, Robert W. Lord, Mark A. Malamud,        John D. Rinaldo, Jr., and Lowell L. Wood, Jr. as inventors,        filed Jul. 24, 2006, now issued as U.S. Pat. No. 8,146,161;    -   (5) For purposes of the USPTO extra-statutory requirements, the        present application constitutes a continuation-in-part of U.S.        patent application Ser. No. 11/487,595 entitled “GENERATING AND        DISTRIBUTING A MALWARE COUNTERMEASURE”, naming Edward K.Y. Jung,        Royce A. Levien, Robert W. Lord, Mark A. Malamud, and William        Henry Mangione-Smith as inventors, filed Jul. 14, 2006, which is        currently co-pending, or is an application of which a currently        co-pending application is entitled to the benefit of the filing        date;    -   (6) For purposes of the USPTO extra-statutory requirements, the        present application constitutes a continuation-in-part of U.S.        patent application Ser. No. 11/486,975 entitled “EFFICIENT        DISTRIBUTION OF A MALWARE COUNTERMEASURE”, naming Edward K.Y.        Jung, Royce A. Levien, Robert W. Lord, Mark A. Malamud, and        William Henry Mangione-Smith as inventors, filed Jul. 14, 2006,        now issued as U.S. Pat. No. 8,539,581;    -   (7) For purposes of the USPTO extra-statutory requirements, the        present application constitutes a continuation-in-part of U.S.        patent application Ser. No. 11/480,782 entitled “SMART        DISTRIBUTION OF A MALWARE COUNTERMEASURE”, naming Edward K.Y.        Jung, Royce A. Levien, Robert W. Lord, Mark A. Malamud, and        William Henry Mangione-Smith as inventors, filed Jun. 30, 2006,        now issued as U.S. Pat. No. 8,613,095;    -   (8) For purposes of the USPTO extra-statutory requirements, the        present application constitutes a continuation-in-part of U.S.        patent application Ser. No. 11/480,819 entitled “IMPLEMENTATION        OF MALWARE COUNTERMEASURES IN A NETWORK DEVICE”, naming Edward        K.Y. Jung, Royce A. Levien, Robert W. Lord, Mark A. Malamud, and        William Henry Mangione-Smith as inventors, filed Jun. 30, 2006,        now issued as U.S. Pat. No. 8,117,654;    -   (9) For purposes of the USPTO extra-statutory requirements, the        present application constitutes a continuation-in-part of U.S.        patent application Ser. No. 11/474,523 entitled “VIRUS        IMMUNIZATION USING PRIORITIZED ROUTING”, naming Edward K.Y.        Jung, Royce A. Levien, Robert W. Lord, Mark A. Malamud, John D.        Rinaldo, Jr., and Lowell L. Wood, Jr. as inventors, filed Jun.        22, 2006, now issued as U.S. Pat. No. 8,191,145; and    -   (10) For purposes of the USPTO extra-statutory requirements, the        present application constitutes a continuation-in-part of U.S.        patent application Ser. No. 11/413,969 entitled “MULTI-NETWORK        VIRUS IMMUNIZATION”, naming Edward K.Y. Jung, Royce A. Levien,        Robert W. Lord, Mark A. Malamud, John D. Rinaldo, Jr., and        Lowell L. Wood, Jr. as inventors, filed April 27, 2006, now        issued as U.S. Pat. No. 7,917,956.

RELATED APPLICATIONS

None.

The United States Patent Office (USPTO) has published a notice to theeffect that the USPTO's computer programs require that patent applicantsreference both a serial number and indicate whether an application is acontinuation, continuation-in-part, or divisional of a parentapplication. Stephen G. Kunin, Benefit of Prior-Filed Application, USPTOOfficial Gazette Mar. 18, 2003. The USPTO further has provided forms forthe Application Data Sheet which allow automatic loading ofbibliographic data but which require identification of each applicationas a continuation, continuation-in-part, or divisional of a parentapplication. The present Applicant Entity (hereinafter “Applicant”) hasprovided above a specific reference to the application(s) from whichpriority is being claimed as recited by statute. Applicant understandsthat the statute is unambiguous in its specific reference language anddoes not require either a serial number or any characterization, such as“continuation” or “continuation-in-part,” for claiming priority to U.S.patent applications. Notwithstanding the foregoing, Applicantunderstands that the USPTO's computer programs have certain data entryrequirements, and hence Applicant has provided designation(s) of arelationship between the present application and its parentapplication(s) as set forth above and in any ADS filed in thisapplication, but expressly points out that such designation(s) are notto be construed in any way as any type of commentary and/or admission asto whether or not the present application contains any new matter inaddition to the matter of its parent application(s).

If the listings of applications provided above are inconsistent with thelistings provided via an ADS, it is the intent of the Applicant to claimpriority to each application that appears in the Priority Applicationssection of the ADS and to each application that appears in the PriorityApplications section of this application.

All subject matter of the Priority Applications and the RelatedApplications and of any and all parent, grandparent, great-grandparent,etc. applications of the Priority Applications and the RelatedApplications, including any priority claims, is incorporated herein byreference to the extent such subject matter is not inconsistentherewith.

If an Application Data Sheet (ADS) has been filed on the filing date ofthis application, it is incorporated by reference herein. Anyapplications claimed on the ADS for priority under 35 U.S.C. §§119, 120,121, or 365(c), and any and all parent, grandparent, great-grandparent,etc. applications of such applications, are also incorporated byreference, including any priority claims made in those applications andany material incorporated by reference, to the extent such subjectmatter is not inconsistent herewith.

SUMMARY

An embodiment provides a method. In one implementation, the methodincludes but is not limited to determining a virus associated with acommunications network, and distributing an anti-viral agent onto thecommunications network using a bypass network, the bypass networkconfigured to provide transmission of the anti-viral agent with at leastone of a higher transmission speed, a higher transmission reliability, ahigher transmission security, and/or a physically-separate transmissionpath, relative to transmission of the virus on the communicationsnetwork. In addition to the foregoing, other method aspects aredescribed in the claims, drawings, and text forming a part of thepresent disclosure.

An embodiment provides a computer program product. In oneimplementation, the computer program product includes but is not limitedto a signal-bearing medium bearing at least one of one or moreinstructions for determining a virus associated with a communicationsnetwork, and the signal bearing medium bearing one or more instructionsfor distributing an anti-viral agent onto the communications networkusing a bypass network, the bypass network configured to providetransmission of the anti-viral agent with at least one of a highertransmission speed, a higher transmission reliability, a highertransmission security, and/or a physically-separate transmission path,relative to transmission of the virus on the communications network. Inaddition to the foregoing, other computer program product aspects aredescribed in the claims, drawings, and text forming a part of thepresent disclosure.

An embodiment provides a system. In one implementation, the systemincludes but is not limited to a computing device and instructions. Theinstructions when executed on the computing device cause the computingdevice to determine a virus associated with a communications network,and distribute an anti-viral agent onto the communications network usinga bypass network, the bypass network configured to provide transmissionof the anti-viral agent with at least one of a higher transmissionspeed, a higher transmission reliability, a higher transmissionsecurity, and/or a physically-separate transmission path, relative totransmission of the virus on the communications network. In addition tothe foregoing, other system aspects are described in the claims,drawings, and text forming a part of the present disclosure.

An embodiment provides a device. In one implementation, the deviceincludes but is not limited to a multi-network virus immunizationsystem, and the multi-network virus immunization system includes but isnot limited to a network monitor operable to determine a virusassociated with a communications network, and a response generatoroperable to distribute an anti-viral agent onto the communicationsnetwork using a bypass network, the bypass network configured to providetransmission of the anti-viral agent with at least one of a highertransmission speed, a higher transmission reliability, a highertransmission security, and/or a physically-separate transmission path,relative to transmission of the virus on the communications network. Inaddition to the foregoing, other device aspects are described in theclaims, drawings, and text forming a part of the present disclosure.

In addition to the foregoing, various other embodiments are set forthand described in the text (e.g., claims and/or detailed description)and/or drawings of the present description.

The foregoing is a summary and thus contains, by necessity,simplifications, generalizations and omissions of detail; consequently,those skilled in the art will appreciate that the summary isillustrative only and is not intended to be in any way limiting. Otheraspects, features, and advantages of the devices and/or processesdescribed herein, as defined by the claims, will become apparent in thedetailed description set forth herein.

BRIEF DESCRIPTION OF THE DRAWINGS

FIG. 1 illustrates an example multi-network virus immunization system inwhich embodiments may be implemented, perhaps in a device.

FIG. 2 illustrates example embodiments of a communications network ofthe multi-network virus immunization system of FIG. 1.

FIG. 3 illustrates example embodiments of bypass network(s) of themulti-network virus immunization system of FIG. 1.

FIG. 4 illustrates an operational flow representing example operationsrelated to techniques for multi-network virus immunization.

FIG. 5 illustrates an alternative embodiment of the example operationalflow of FIG. 4.

FIG. 6 illustrates an alternative embodiment of the example operationalflow of FIG. 4.

FIG. 7 illustrates an alternative embodiment of the example operationalflow of FIG. 4.

FIG. 8 illustrates an alternative embodiment of the example operationalflow of FIG. 4.

FIG. 9 illustrates an alternative embodiment of the example operationalflow of FIG. 4.

FIG. 10 illustrates an alternative embodiment of the example operationalflow of FIG. 4.

FIG. 11 illustrates an alternative embodiment of the example operationalflow of FIG. 4.

FIG. 12 illustrates an alternative embodiment of the example operationalflow of FIG. 4.

FIG. 13 illustrates an alternative embodiment of the example operationalflow of FIG. 4.

FIG. 14 illustrates an alternative embodiment of the example operationalflow of FIG. 4.

FIG. 15 illustrates an alternative embodiment of the example operationalflow of FIG. 4.

FIG. 16 illustrates an alternative embodiment of the example operationalflow of FIG. 4.

FIG. 17 illustrates an alternative embodiment of the example operationalflow of FIG. 4.

FIG. 18 illustrates an alternative embodiment of the example operationalflow of FIG. 4.

FIG. 19 illustrates a partial view of an example computer programproduct that includes a computer program for executing a computerprocess on a computing device.

FIG. 20 illustrates an example system in which embodiments may beimplemented.

The use of the same symbols in different drawings typically indicatessimilar or identical items.

DETAILED DESCRIPTION

FIG. 1 illustrates an example multi-network virus immunization system100 in which embodiments may be implemented. In the example of FIG. 1,the multi-network virus immunization system 100 is operable, forexample, to prevent or reduce damage caused by malicious software code,or otherwise limit a propagation and/or replication of any undesiredcode or behavior within a computer network. For example, themulti-network virus immunization system 100 may be operable to limitpropagation/replication of undesired code within a first network byinitiating a competing and inherently-advantaged propagation/replicationof desired code, using a second network.

In the example of FIG. 1, an example of such a first network isillustrated as a communications network 102. The communications network102 may include, for example, virtually any computer network over whichusers and/or network devices may conduct a mutually-desirable exchangeof information, where such mutually-desirable information may includeand/or be referred to as communications data. For example, suchcommunications data may include voice or e-mail traffic that is desiredby both a sending and a receiving party, or may include a file transfer(including, for example, a video and/or audio file transfer) desired byboth a sending and a receiving party. The communications network 102 mayinclude, for example, a virtual local area network, a virtual privatenetwork (VPN), and/or a corporate intranet, and, in such examples, maybe implemented as part of (e.g., as a subset of) a larger network, suchas, for example, the public Internet. Other examples of thecommunications network 102 and of communications data are provided inmore detail, herein.

Further in the example of FIG. 1, an example of the second networkreferenced above as part of the multi-network virus immunization system100 may include a logical bypass network 104 and/or a physical bypassnetwork 106, and/or other example(s) of a bypass network(s), asdescribed in more detail, herein. For example, the logical bypassnetwork 104 may include a computer network that is at least partiallylogically separate from the communications network 102 (e.g., at leastone or more segments of the logical bypass network 104 may be logicallyseparate from the communications network 102). For example, thecommunications network 102 and the logical bypass network 104 may bothbe implemented on an identical set (or sub-set(s)) of computing devicesthat are physically connected to one another, but that implementdifferent network protocols, or that implement different instances ofthe same or similar network protocols, or that are implemented atdifferent layers of a protocol stack, or are otherwiselogically-separated from one another.

For instance, a computer that is common to both the communicationsnetwork 102 and the logical bypass network 104 may be assigned a firstInternet Protocol (IP) address on the communications network 102, and asecond IP address on the logical bypass network 104. It should beunderstood that computers common to the communications network 102 andto the logical bypass network 104 may share a common hub or switch, orother network device(s), but may nonetheless representlogically-separate networks that are generally incapable ofcommunicating with one another without some type of translation ormediation therebetween. For example, as discussed in more detail herein,such translation and/or mediation may occur at a router or gateway thatconnects the communications network 102 and the logical bypass network104.

The physical bypass network 106 represents, for example, a network thatis at least partially physically separate from the communicationsnetwork 102. For example, the physical bypass network 106 may includecomputers or other network devices that are different physical devicesthan those found on the communications network 102, and/or thatcommunicate using different (types of) transmission media and/ortechniques, and/or that are configured using a physically distinctnetwork topology. For example, where the communications network 102 mayinclude one or more local area networks (LANs) connected together in awired fashion (e.g., using Ethernet and/or fiber), the physical bypassnetwork 106 may include a satellite-based network, or a cellularnetwork, or some other physically separate network, examples of whichare discussed in more detail, herein.

Of course, although the example of FIG. 1 illustrates the logical bypassnetwork 104 and the physical bypass network 106, it should be understoodthat these are merely intended as non-limiting examples, and thatadditional or alternative examples of bypass network(s) may be used inthe multi-network immunization system 100. Further, although both thelogical bypass network 104 and the physical bypass network 106 areillustrated in FIG. 1, it should be clear that, in any givenimplementation of the multi-network immunization system 100 (such asthose described herein), only one such bypass network may be used.

As referenced herein, the logical bypass network 104 and/or the physicalbypass network 106 may be used to prevent or reduce apropagation/replication of undesired code or behavior on thecommunications network 102. In the example of FIG. 1, a virus 108 isillustrated that represents and includes any such undesired code orbehavior, including but not limited to, for example, malicious code thatis created and/or distributed within the communications network 102 by aparty desiring to harm or otherwise inconvenience users of thecommunications network 102. For example, the virus 108 may includeself-replicating and/or self-propagating (and perhaps evolving) codethat may infect network devices of the communications network 102, soas, for example, to destroy, modify, or create data on such networkdevice(s). More generally, the virus 108 may represent and includevirtually any code that attacks a confidentiality, integrity,availability, accountability, and/or accuracy of a device and/ortransmission of the communications network 102. Even more generally, thevirus 108 need not be malicious in the sense(s) just referenced, but maysimply be undesired on the communications network 102 by anadministrator or other user of the communications network 102. Furtherexamples of the virus 108 are provided in more detail, herein.

An immunization system 110 is illustrated in the example of FIG. 1 thatis operable to determine the virus 108 that is associated with thecommunications network 102. The immunization system 110 is furtheroperable to distribute an anti-viral agent 112 and/or an anti-viralagent 114 onto the communications network 102 using a bypass network,e.g., the logical bypass network 104 and/or the physical bypass network106. The logical bypass network 104 and/or the physical bypass network106 is/are configured to provide transmission of the anti-viral agent112 and/or the anti-viral agent 114 with at least one of a highertransmission speed, a higher transmission reliability, a highertransmission security, and/or a physically-separate transmission path,relative to transmission of the virus 108 on the communications network102. In this way, the virus 108 may be prevented or limited fromspreading or existing on the communications network 102.

In this regard, it should be understood that the virus 108 mayreplicate, exist, and/or propagate on the communications network 102 ina manner(s) that may be very fast and/or difficult to detect and/ordestroy. In fact, in many cases, the virus 108 may be specificallyengineered to be difficult to contain within the communications network102. For example, the virus 108 may spread in a multi-cast or broadcastfashion, and may infect devices of the communications network 102 in avirtually exponential progression. In other examples, the virus 108 maybe designed to infect devices of the communications network 102 and totake no action on an infected network device 116 of the communicationsnetwork 102, at least initially, while the virus 108 spreads to a largernumber of network devices. Then, the virus 108 may execute (e.g., aftersome pre-designated time or signal), so that a large number ofalready-infected and damaged devices are determined at once. Thus, inmany cases, the virus 108 may have an inherent advantage (e.g., a“head-start”) in propagating on the communications network 102,particularly since, for example, a curative or mitigating response tothe virus 108 often may not be developed with sufficient specificity andeffectiveness until the virus 108 is sufficiently examined and analyzed.

The multi-network virus immunization system 100 thus uses a bypassnetwork, such as the logical bypass network 104 and/or the physicalbypass network 106, to provide an alternate, out-of-band, or otherwiseadvantageous channel and/or path for transmission of the anti-viralagent 112 (and/or the anti-viral agent 114). As described herein, one ormore characteristics and/or metrics of such bypass network(s) may enabledistribution of the anti-viral agent(s) 112, 114 in an advantageousmanner that enhances an effectiveness thereof in preventing or limitingthe virus 108 on the communications network 102.

For example, the logical bypass network 104 may provide transmission ofthe anti-viral agent 112 to a non-infected network device 118 of thecommunications network 102 with a greater transmission speed, lowerlatency, effective speed, and/or faster delivery time than provided bythe communications network 102 in delivering the virus 108 from theinfected network device 116 to the non-infected network device 118. Moregenerally, as the virus 108 spreads through the communications network102, the immunization system 110 may use the logical bypass network 104to distribute the anti-viral agent 112 ahead of the spreading of thevirus 108. In this way, the anti-viral agent 112 may immunizenon-infected (e.g., not-yet infected) network devices of thecommunications network 102, including the non-infected network device118, against the virus 108. Accordingly, the spread of the virus 108 onthe communications network 102 may be slowed or stopped, as fewer andfewer network devices on the communications network 102 are available aspossible hosts for the virus 108.

Similar comments apply to the physical bypass network 106 indistributing the anti-viral agent 114. Moreover, as described herein,other characteristics and/or metrics associated with the physical bypassnetwork 106 (and/or the logical bypass network 104) may be utilized indistributing the anti-virus agent 114 (and/or the anti-virus agent 112)on the communications network 102. For example, the physical bypassnetwork 106 may provide transmission of the anti-viral agent 114 with agreater reliability and/or greater security than is available to thecommunications network 102 in transmitting the communications dataand/or the virus 108. Greater reliability in this sense may include, forexample, point-to-point and/or end-to-end reliability in transmittingthe anti-viral agent 114 than is available to the communications network102. Similarly, greater security may include, for example, greaterpoint-to-point and/or end-to-end security (e.g., encryption). By usingan effectively higher reliability and/or security, the physical bypassnetwork 106 may increase the probability or expectation that theanti-viral agent 114 may be delivered to the communications network 102in a way that is effective in stopping or otherwise limiting the spreadof the virus 108.

In some example implementations, the anti-viral agent(s) 112, 114 alsomay be self-replicating and/or self-propagating. Thus, once deployedonto the communications network 102, the anti-viral agents 112, 114 mayspread to a plurality of non-infected devices thereof, so that suchnon-infected devices may be rapidly immunized against the spread of thevirus 108. Due to the advantage(s) provided by the characteristics ofthe logical bypass network 104 and the physical bypass network 106,respectively, the anti-viral agents 112, 114 may compensate for, orovercome, any advantages experienced by the virus 108 in propagating onthe communications network 102, and may therefore be effective instopping or otherwise limiting the propagation of the virus 108.

In the example of FIG. 1, the immunization system 110 includes a networkmonitor 120 that is operable to determine the virus 108 on thecommunications network 102. For example, the network monitor 120 maydetect and/or identify the virus 108, by, for example, implementingdetection rules 122, and/or using known virus data 124. For example, thedetection rules 122 may specify parameters for selecting and scanningnetwork devices of the communications network 102 (e.g., which or howmany network devices should be scanned, and with what frequency), andthe network monitor 120 may implement these and/or other examples of thedetection rules 122. The network monitor 120 also may determine thevirus 108 using known virus data 124, e.g., by comparing a signature ofthe virus 108 with known virus signatures stored therein, according tothe detection rules 122. Various other examples of the nature andoperation of the network monitor 120, the detection rules 122, and thevirus data 124 are provided in more detail, herein.

The immunization system 110 also includes a response generator 126 thatis operable to communicate with the network monitor 120 to generate aresponse to the virus 108. The response generator 126 may act accordingto response rules 128 that may govern, for example, a creation of theanti-viral agents 112, 114 and/or a distribution of the anti-viralagents 112, 114 using the logical bypass network 104 and/or the physicalbypass network 106. For example, the response generator 126 may use theresponse rules 128 to determine which of the logical bypass network 104and the physical bypass network 106 to use (in a case where both areavailable), or where and how to inject the anti-viral agents 112, 114onto the communications network 102. The response rules 128 also maygovern a manner in which the response generator 126 uses anti-viralagent data 130 to create, distribute, or otherwise provide the virus108. For example, the response generator 126 may select from severalpossible anti-viral agents and/or distribution strategies available inthe anti-viral agent data 130, based on information provided by thenetwork monitor 120 and/or based on the response rules 128.

As another example, the response generator 126 may provide theanti-viral agent 114 by first distributing a reference 132 to theanti-viral agent 114 on the communications network 102, using thephysical bypass network 106. For example, the reference 132 may includea pointer, link, or other identifier of the anti-viral agent 114, sothat, for example, the non-infected network device 118 may obtain orotherwise access the actual anti-viral agent 114 itself, e.g., from theanti-viral agent data 130. Various other examples of the nature andoperation of the response generator 126, the response rules 128, and/orthe anti-viral agent data 130 are provided in more detail, herein.

In FIG. 1, the immunization system 110 is illustrated as beingimplemented on a (single, generic) device 134, which may representvirtually any computing device(s) capable of executing the functions andfeatures described herein, including, for example, a desktop computer, aworkstation computer, a server, a personal digital assistant (PDA) orcell phone, a laptop computer, a tablet personal computer, a networkedcomputer, or a computing system comprised of a cluster of processors.Further, the immunization system 110 may be implemented in whole or inpart on (or in association with) the infected network device 116, thenon-infected network device 118, a network traffic manager 136associated with the communications network 102 and the logical bypassnetwork 104, or a network traffic manager 138 between the communicationsnetwork 102. For example, the network traffic managers 136, 138 mayinclude router(s), gateway(s), firewall(s), or other devices forimplementing network policies and/or managing network traffic.

For example, the network traffic manager 136 may represent a router thatprovides translation between the communications network 102 and thelogical bypass network 104, and that may be present on both of thecommunications network 102 and the logical bypass network 104. In somesuch example implementations, the network traffic manager 136 mayimplement the network monitor 120 and the detection rules 122 to detectthe virus 108 on the communications network, and/or may implement theresponse generator 126 and/or the response rules 128 to distribute theanti-viral agent 112.

For example, the network traffic manager 136 may include atag-prioritized router (e.g., implementing Multiprotocol Label Switching(MPLS)) that is operable to recognize and prioritize network trafficthat is tagged as being associated with the anti-viral agent 112. Forexample, the top “n” tags of network traffic may be reserved on thenetwork traffic manager 136 as being associated with the anti-viralagent 112. In this way, for example, the anti-viral agent 112 may beprovided ahead of the virus 108 on the communications network 102, evenwhen the communications network 102 and the logical network 104 sharethe same computing devices and/or network traffic manager(s).

Also in FIG. 1, an entity 140 is illustrated as owning, assuring,guaranteeing, providing, or otherwise sponsoring the logical bypassnetwork 104 and/or the physical bypass network 106. Although notdirectly illustrated in FIG. 1, it should be understood that the entity140, or a different entity (not shown in FIG. 1) may sponsor thecommunications network 102, as well. Accordingly, the entity 140 may beresponsible for implementing some or all of the immunization system 110in conjunction with one or more of the communications network 102, thelogical bypass network 104, the physical bypass network 106, and/or thenetwork traffic managers 136, 138.

For example, the entity 140 may represent one or more of a networkservice provider or an antiviral service provider, and/or may representa third-party entity that billing or other services associated withdefining or providing the communications network 102 on behalf of anetwork service provider (e.g., may provide the communications network102 as a virtual private network (VPN) having defined or desiredcharacteristics or users, in exchange for a fee(s)). As such, (accessto) one or more of the communications network 102, the logical bypassnetwork 104, and/or the physical bypass network 106, may be provided inconjunction with a service level agreement (SLA) between the entity anda recipient/user of one or more of the communications network 102, thelogical bypass network 104, and/or the physical bypass network 106.Thus, one or more of the communications network 102, the logical bypassnetwork 104, and/or the physical bypass network 106 may be considered tobe a managed network, e.g., managed by the entity 140. As such, one ormore of the communications network 102, the logical bypass network 104,and/or the physical bypass network 106 may be operated essentiallyindependently of one another and/or using separate/distinct managementconsoles.

Thus, as should be understood from the description provided herein, auser 142 may be provided with (or provided with access to) one or moreof the communications network 102, the logical bypass network 104,and/or the physical bypass network 106. The user 142 may include, forexample, a single consumer, employee, service provider, or otherperson(s), or may represent a corporation or other entity (e.g., acorporation providing the communications network 102 to employees aspart of a corporate intranet).

Accordingly, the user 142 may obtain the benefit(s) of one or more ofthe communications network 102, the logical bypass network 104, and/orthe physical bypass network 106, in exchange for payment provided to theentity 140. In this context, payment may refer generally to any type ofmonetary compensation, and/or non-monetary compensation, and/or economicvalue exchange. By way of example and not limitation, a payment mayinclude a non-monetary payment, including a reduced or eliminated costto the user 142, in exchange for a granting of certain rights orpermissions to the entity 140 (such as, for example, granting the entity140 rights to certain information of the user 142, including personalinformation of the user 142 for maintaining in a database for marketingor research purposes).

FIG. 2 illustrates example embodiments of the communications network ofthe multi-network virus immunization system of FIG. 1. In FIG. 2, thecommunications network 102 is illustrated as potentially including oneor more of the public internet 202, a subset of the public internet 202such as a commodity network 204 (e.g., a VPN), a corporate intranet 206,a peer-to-peer network 208, a satellite network 210, or a specific typeof the satellite network 210 such as a satellite radio network 212. Ofcourse, the examples in FIG. 2 are non-limiting examples of thecommunications network 102, and many other examples and implementationsmay be used. As should be understood from the description providedherein, the entity 140 may be associated with providing, or providingaccess to, one or more of the example networks 202-212 illustrated inFIG. 2.

FIG. 3 illustrates example embodiments of the bypass network(s) 104, 106of the multi-network virus immunization system of FIG. 1. FIG. 2illustrates a bypass network 302 that should be understood to representor include one or both of the logical bypass network 104 and/or thephysical bypass network 106, and/or another bypass network(s). As shown,and described in more detail herein, the bypass network 302 may beconfigured to provide one or more of a higher transmission speed 304, ahigher transmission reliability, and/or a physically-separatetransmission path 308, and a higher transmission security 310 relativeto transmission of the virus 108 on the communications network 102.

In so doing, and as just referenced, the bypass network 302 may use thephysical bypass network 106 and/or the logical bypass network 104. InFIG. 3, examples of the physical bypass network 106 are illustrated asincluding one or more of a satellite network 312 (including,potentially, a satellite radio network 314), a cellular network 316, ora peer-to-peer network 318 (including, potentially, a separatepeer-to-peer network 320 that may be provided in conjunction with, butseparately or independently from, the communications network 102, e.g.,the peer-to-peer network 208).

Further in FIG. 3, the logical bypass network 104 is illustrated asincluding an analog channel on a digital link 322, including, forexample, an analog channel on a digital/broadband cable network 324. Thelogical bypass network 104 also may include prioritized router traffic,such as, for example, the prioritized router traffic described hereinwith respect to the network traffic manager 136.

The entity 140 is illustrated in FIG. 3 as sponsoring or otherwiseproviding (or providing access to) the bypass network 302. Of course, itshould be understood that the entity 140 may represent one or moreentities, and that a different entity may sponsor or provide thecommunications network 102 than the entity that provides the bypassnetwork 302.

Further in FIG. 3, the networks 104, 106, and 304-324 are illustratedwith dashed lines to illustrate examples of how the bypass network 302may be provided. Of course, again, the illustrated connections aremerely illustrative, and are not limiting as to how the bypassnetwork(s) may be connected, inter-connected, or otherwise provided.

FIG. 4 illustrates an operational flow 400 representing exampleoperations related to techniques for multi-network virus immunization.In FIG. 4 and in following figures that include various examples ofoperational flows, discussion and explanation may be provided withrespect to the above-described examples of FIGS. 1-3, and/or withrespect to other examples and contexts. However, it should be understoodthat the operational flows may be executed in a number of otherenvironments and contexts, and/or in modified versions of FIGS. 1-3.Also, although the various operational flows are presented in thesequence(s) illustrated, it should be understood that the variousoperations may be performed in other orders than those which areillustrated, or may be performed concurrently.

After a start operation, the operational flow 400 moves to a determiningoperation 410 in which a virus associated with the communicationsnetwork may be determined. For example, as shown in FIG. 1, the networkmonitor 120 of the immunization system 110 may be operable to monitorthe communications network 102, e.g., according to the detection rules122, in order to detect the virus 108 associated with the communicationsnetwork 102. In other examples, the virus 108 may represent a potentialvirus and/or a virus that is thought (without certainty) to exist, andmay be determined to be associated with the communications network inthe sense that the communications network 102 is particularlysusceptible to a type of the (potential) virus 108. In such cases, thevirus 108 may not yet exist, or may not yet actually be distributed ontothe communications network 102 (e.g., a malicious provider of the virus108 may merely have threatened distribution of the virus 108).

Then, in a distributing operation 420, an anti-viral agent may bedistributed onto the communications network using a bypass network, thebypass network configured to provide transmission of the anti-viralagent with at least one of a higher transmission speed, a highertransmission reliability, a higher transmission security, and/or aphysically-separate transmission path, relative to transmission of thevirus on the communications network. For example, the immunizationsystem 110 may distribute the anti-viral agent 112 to the communicationsnetwork 102 using the logical bypass network 104, where the logicalbypass network 104 may provide the anti-viral agent 112 to thecommunications network 102 using the network traffic manager 136 and/orthe non-infected network device 118. In another example, theimmunization system 110 may distribute the anti-viral agent 114 to thecommunications network 102 using the physical bypass network 106, wherethe physical bypass network 106 may provide the anti-viral agent 114 tothe communications network 102 using the network traffic manager 138and/or the non-infected network device 118. In a more specific example,the response generator 126 may be operable to (a) create, formulate, orobtain the anti-viral agents 112, 114, (b) determine an optimal bypassnetwork(s) for distribution of the anti-viral agents 112, 114 (e.g.,determine characteristics of the logical bypass network 104 and/or thephysical bypass network 106 that are best-suited for distributing theanti-viral agents 112, 114 and limiting the virus 108), and (c)determine a distribution strategy for distributing the anti-viral agents112, 114 onto the communications network 102 (e.g., distributing theanti-viral agents 112, 114 onto a network device of the communicationsnetwork 102 that has a high degree of connectivity within thecommunications network 102 and therefore provides for rapiddissemination of the anti-viral agents 112, 114.

As a result of the operations 410-420, operation(s) may be performedthat are related either to a local or remote storage of digital data, orto another type of transmission of digital data. As discussed herein, inaddition to accessing, querying, recalling, or otherwise determining thedigital data for the determining operation 410 and/or the distributingoperation 420, operations may be performed related to storing,assigning, associating, or otherwise archiving the digital data to amemory, including, for example, sending and/or receiving a transmissionof the digital data from a remote memory. Accordingly, any suchoperation(s) may involve elements including at least an operator (e.g.,either human or computer) directing the operation, a transmittingcomputer, and/or a receiving computer, and should be understood to occurwithin the United States as long as at least one of these elementsresides in the United States.

FIG. 5 illustrates alternative embodiments of the example operationalflow 400 of FIG. 4. FIG. 5 illustrates example embodiments where thedetermining operation 410 may include at least one additional operation.Additional operations may include an operation 502, an operation 504, anoperation 506, an operation 508, an operation 510, and/or an operation512.

At the operation 502, the virus may be detected on a network device ofthe communications network. For example, the virus 108 may be sent as,or in association with, an e-mail to the (infected) network device 116of the communications network 102, and the user 142 may open the e-mailto enable the virus 108 to infect the (infected) network device 116.Then, for example, the network monitor 120 of the immunization system110 may detect the virus 108 on the infected network device 116 of thecommunications network 102, e.g., by comparing the virus 108 (or aheader, payload, and/or signature thereof) against virus data 124, inaccordance with the detection rules 122. In such examples, the networkmonitor 120 may be implemented as an anti-viral program running on theinfected network device 116, and/or may represent an anti-viral programrunning on a separate device (e.g., the device 134) that detects thevirus 108 (including multiple instances thereof) on a plurality ofnetwork devices of the communications network 102.

At the operation 504, a propagation of the virus may be detected betweennetwork devices of the communications network. For example, where thevirus 108 has infected the infected network device 116 of thecommunications network 102, the virus 108 may, for example, propagateusing the communications network 102 to (attempt to) reach thenon-infected network device 118. During such propagation, which mayoccur, for example, over the network traffic manager 136/138 the networkmonitor 120 of the immunization system 110 may detect the virus 108using the detection rules 122. Again, in the latter example, the networkmonitor 120 and/or the immunization system 110 as a whole may beimplemented on the network traffic manager 136/138, or partially orwholly separate therefrom.

At the operation 506, an effect of the virus with respect to thecommunications network may be detected. For example, the virus 108 mayhave an effect such as slowing or preventing some or all transmission ofcommunications data on the communications network 102 by some measurableamount. In such cases, for example, the network monitor 120 of theimmunization system 110, perhaps using the detection rules 122, maydetect the slowing effect of the virus 108. In an additional oralternative example, the virus 108 may have the effect of disablingaccess to the e-mail program (or some other application) of the infectednetwork device 116, or may delete certain files from the infectednetwork device 116. In such an example(s), again, the network monitor120 may detect (e.g., infer a presence of) the virus 108 on the infectednetwork device 116, e.g., by applying the detection rules 122.

At the operation 508, a potential for propagation of the virus on thecommunications network may be determined. For example, the virus 108 maybe known to infect communications networks with a particular securityshortcoming or loophole. Thus, in a case where the communicationsnetwork 102 is associated with the security shortcoming/loophole, it maybe determined that the communications network 102 is susceptible to thevirus 108, e.g., that there may be a potential for propagation of thevirus 108 on the communications network 102.

At the operation 510, a signature associated with a network device onwhich the virus is present and/or was present may be determined. Forexample, the virus 108 may have a known signature (which may be storedin the virus data 124), and may infect the infected network device 116.Monitoring of the infected network device 116 may provide observation ordetermination of such a signature, which may be considered, for example,to be an “epitopic signature” that is analogous to human immuneresponses for identifying a post-infected body part. The network monitor120 of the immunization system 110 may thus determine the signature.Then, at the operation 512, the virus 108 may be determined based on thesignature. In continuing the example just given, the network monitor 120of the immunization system 110 may thus use the detection rules 122 todetermine that the signature of the operation 510 is, in fact, thesignature of the virus 108. It should be understood that the virus 108need not be determined with any particular degree of specificity. Forexample, the network monitor 120 may simply determine (e.g., based on achecksum of key code received from the infected network device 116) thatthe infected network device 116 is suspicious (e.g., due to anon-matching checksum). As a result, particularly when aggregated withsimilar results obtained from other network devices, the virus 108 maybe recognized at some level, and attacks using the virus 108 (e.g.,denial-of-service attacks in which the virus 108 causes the infectednetwork device(s) 116 to flood a host device with service requests so asto block access to the host for other network devices) may be thwarted.For example, the host device may stop accepting requests from networkdevices suspected of being involved in the attack. It should beunderstood, of course, that the signature (e.g., checksum) may beprovided to the host device using the logical bypass network 104 and/orthe physical bypass network 106.

FIG. 6 illustrates alternative embodiments of the example operationalflow 400 of FIG. 4. FIG. 6 illustrates example embodiments where thedetermining operation 410 may include at least one additional operation.Additional operations may include an operation 602, an operation 604, anoperation 606, an operation 608, an operation 610, an operation 612, anoperation 614, an operation 616, and/or an operation 618.

At the operation 602, a comparison may be performed of a signatureassociated with the virus with one or more known signatures. Forexample, as described herein, the virus 108 may have a signature, e.g.,associated with a header, packet, or payload of the virus 108. Theimmunization system 110 (e.g., the network monitor 120) may then, forexample, compare the signature of the virus 108 to the set of knownand/or authorized signatures for the communications network 102, as maybe stored in the virus data 124. Of course, the network monitor 120 alsomay compare the signature of the virus 108 against a set of known virussignatures in the virus data 124. At the operation 604, the virus may bedetermined based on the comparison. For example, where the detectionrules 122 are used to compare the signature of the virus 108 against aset of known authorized signatures, the network monitor 120 maydetermine that the signature does not match any of the known authorizedsignatures, and thus may determine that the signature is associated witha virus, e.g., the virus 108. Where the detection rules 122 are used tocompare the signature of the virus 108 against a set of known virussignatures, the network monitor 120 may determine that the signaturedoes (or does not) match a known virus signature(s), and thus maydetermine that the signature is that of the virus 108.

At the operation 606, a notification of the virus from a virus detectionprogram may be received. For example, a virus detection program mayinclude at least a portion of the network monitor 120, which may berunning on (or in association with) the communications network 102(e.g., the infected network device 116). Then, the immunization system110 (e.g., a secondary/remote portion of the network monitor 120, alongwith the detection rules 122, and/or the virus data 124) may receive anotification of the virus from the virus detection program. At theoperation 608, the virus may be determined, based on the notification.For example, the secondary/remote portion of the network monitor 120 mayreceive the notification from the virus detection program running on theinfected network device 116, and may then determine the virus 108 by,for example, implementing the detection rules 122.

At the operation 610, a fault pattern associated with the virus and/orthe communications network may be determined. For example, after thevirus 108 infects the (one or more) infected network device(s) 116and/or the communications network 102, the virus 108 may cause a faultpattern to occur that is detectable by the network monitor 120. Forexample, the network monitor 120 may determine a fault pattern,including, for example, some combination of reduced speed and/oravailable bandwidth of the communications network 102, reduced memory orspeed of the (infected) network device 116, or a suspicious number ofunrecognized executable files on the (infected) network device 116. Suchfault patterns, as a whole, may be sufficient to indicate or identifythe virus 108, where any one aspect of the fault pattern may not besufficient. At the operation 612, the virus is determined based on thefault pattern. For example, after the network monitor 120 determines thefault pattern of the infected network device 116 and/or thecommunications network 102, the network monitor 120 may then apply thedetection rules 122 to determine that the detected fault pattern isassociated with the virus 108.

At the operation 614, a comparison of an expected characteristic of thecommunications network may be performed with an actual characteristic ofthe communications network. For example, the communications network 102may be expected to deliver an e-mail message from a first computer to asecond computer on the communications network 102, within a known amountof time. Then, for example, the communications network 102 may actuallydeliver the e-mail message from the first computer to the secondcomputer in some significantly longer timeframe. The network monitor 120of the immunization system 110 may then, for example, compare theexpected time with the actual time. At the operation 616, the virus maybe determined based on the comparison. For example, the network monitor120 may implement the detection rules 122 to determine that the virus108 is known to cause similar delays in e-mail delivery.

At the operation 618, the virus may be determined, the virus includingcode that is self-propagating within the communications network. Forexample, the virus 108 may include a self-propagating code infecting theinfected network device 116 of the communications network 102, so that,for example, the virus 108 may be configured to propagate from theinfected network device 116, to another network device on thecommunications network 102 (e.g., the non-infected network device 118),without action or assistance of/by the user 142. In an additional oralternative example, the virus 108 may be loaded onto the infectednetwork device 116 of the communications network 102, and may beconfigured to read the e-mail address book of the infected networkdevice 116 and send itself to all of the included addresses on thecommunications network 102, thus propagating itself throughout thecommunications network 102. Other examples of self-propagation may beunderstood to exist in other contexts or implementations of thecommunications network 102, as would be apparent. For example, thecommunications network 102 may represent a plurality of Bluetoothnetworks implemented on a plurality of cell phones and/or personaldigital assistants (PDAs), and the virus 108 may propagate bycommunicating with unsecured Bluetooth connections that may be availableon the plurality of Bluetooth networks, as the user 142 moves from one alocation of one of the Bluetooth networks to a location of another ofthe Bluetooth networks.

FIG. 7 illustrates alternative embodiments of the example operationalflow 400 of FIG. 4. FIG. 7 illustrates example embodiments where thedetermining operation 410 may include at least one additional operation.Additional operations may include an operation 702, an operation 704, anoperation 706, an operation 708, and/or an operation 710.

At the operation 702, the virus may be determined, the virus includingcode that may be self-replicating within the communications network. Forexample, the virus 108 may include self-replicating code on the infectednetwork device 116. The virus 108 may then, for example, replicateitself throughout a plurality of programs and/or files on the infectednetwork device 116. Then, if the infected network device 116 transmits afile over the communications network 102, e.g., to the non-infectednetwork device 118, the self-replicating code may have infected thetransmitted file, and may thus be attached to the file. The immunizationsystem 110, then may, for example, determine the self-replicating code(e.g., the virus 108) on the infected network device 116 and/or on thefile itself, so as to identify or otherwise determine the virus 108.

At the operation 704, the virus may be determined, the virus including amalicious code. For example, the virus 108 may be designed, for example,to erase some or all files on the infected computer 116, or mayotherwise cause harm or inconvenience to the infected network device116, the communications network 102, and/or the user 142.

At the operation 706, the virus may be determined, the virus includingcode associated with one or more of: a network virus, a denial ofservice attack, a network flooding, a worm, a Trojan horse, spyware, anunauthorized network program, and/or adware. For example, the virus 108may be associated with a network flooding, wherein the virus 108 mayoperate on the infected network device(s) 116 to transmit a stream oflarge files from the infected network device 116 onto the communicationsnetwork 102, thus flooding the communications network 102 and making itmore difficult for other network devices to transmit data across thecommunications network 102. In another example, the virus 108 may beassociated with an adware program, wherein the virus 108 may operate onthe infected network device 116 to cause the infected network device 116to display a plurality of ads for products, which may not be requestedor desired by the user 142.

At the operation 708, a feature of the communications network that issusceptible to the virus may be determined. For example, the virus 108may be known to infect communications networks running a particularversion of a particular operating system, or communicating with aparticular network protocol. Thus, for example, the network monitor 120may determine such a feature(s), and may determine the susceptibility ofthe communications network 102 that is caused by such a feature(s). Atthe operation 710, the virus may be determined, based on the feature.For example, the network monitor 120 may apply the detection rules 122to determine that the feature(s) (e.g., operating system or networkprotocol) are associated with, e.g., susceptible to, the virus 108.

FIG. 8 illustrates alternative embodiments of the example operationalflow 400 of FIG. 4. FIG. 8 illustrates example embodiments where thedetermining operation 410 may include at least one additional operation.Additional operations may include an operation 802, an operation 804, anoperation 806, an operation 808, an operation 810 and/or an operation812.

At the operation 802, a feature of a network device of thecommunications network susceptible to the virus is determined. Forexample, the virus 108 may be known to infect a particular type or modelof network device(s), such as, for example, a particular type of cellphone or personal digital assistant. At the operation 804, the virus maybe determined, based on the feature. For example, the immunizationsystem 110 may determine the virus 108, based on the type or model ofthe (infected) network device 116 and/or based on the non-infectednetwork device 118. It should be understood that such determination ofthe virus 108 may occur, as in many other examples described herein,either before, during, or after an infection of the communicationsnetwork 102 (or particular network device thereof) by the virus 108.

At the operation 806, the virus associated with the communicationsnetwork may be determined, the communications network including alogical network configured to route communications data thereon. Forexample, the communications network 102 may include a logical networkdefined on top of an underlying physical network, and the communicationsnetwork 102 may be configured to route communications data, such as, forexample, authorized e-mail traffic or other desired information or filesprovided to or by (and/or authorized by) one or more of the user(s) 142.

At the operation 808, the virus associated with the communicationsnetwork may be determined, the communications network including aphysical network configured to route communications data thereon. Forexample, the communications network 102 may include a physical network,and the communications network 102 may be configured to routecommunications data, that, as just described, may include virtually anyauthorized/desired information provided to or by and/or authorized byone or more of the user(s) 142.

At the operation 810, the virus associated with the communicationsnetwork may be determined, the communications network associated withrestricted access thereto. For example, the communications network 102may be a corporate intranet, wherein only users (e.g., the user 142)having an appropriate login and/or password may have access thereto. Inthese and similar examples, the entity 140 may be responsible forproviding the authorized access to the communications network 102. Inother examples, the user 142 may represent a customer of the entity 140,and may take more direct responsibility for restricting access to thecommunications network.

At the operation 812, the virus associated with the communicationsnetwork may be determined, the communications network associated withfee-based access thereto. For example, the communications network 102may provide network services to the user(s) 142, who may pay a monthlyfee for such network services. As in the examples just referenced, theentity 140 may be responsible for collecting the fee(s) and/orrestricting the access of users who do not pay the fees.

FIG. 9 illustrates alternative embodiments of the example operationalflow 400 of FIG. 4. FIG. 9 illustrates example embodiments where thedetermining operation 410 may include at least one additional operation.Additional operations may include an operation 902, an operation 904, anoperation 906, an operation 908, and/or an operation 910.

At the operation 902, the virus associated with the communicationsnetwork may be determined, the communications network including anentity-assured network. For example, the entity 140 may assure the user142 of the communications network 102 that viruses, such as the virus108, will be limited from propagation on the communications network 102.The user 142 may thus be provided with greater reliance on, andenjoyment of, the communications network 102. Moreover, the user 142need not, in at least some implementations, be required to run and/orupdate anti-virus software at each (or any particular) network device ofthe communications network 102.

At the operation 904, the virus associated with the communicationsnetwork may be determined, the communications network including a subsetof a larger network, and provided in association with the largernetwork. For example, the communications network 102 may include, asshown in FIG. 2 and described herein, the commodity network 204 (e.g., aVPN) as a subset of the public Internet 202.

At the operation 906, the virus associated with the communicationsnetwork may be determined, the communications network including at leastone of: a wide area network, a local area network, a virtual local areanetwork, a virtual private network, a metropolitan area network, apeer-to-peer network, and/or an intranet. Such examples of thecommunications network 102, and other examples, may be understood fromFIG. 2 and the associated description provided herein, e.g., withreference to the networks 202-212. For example, a corporation, as theuser 142, may pay the entity 140 to provide a plurality of local areanetworks (and/or virtual local area networks) that are interconnected bya wide area network, with associated uplinks and connections that allowthe corporation, which may be widely dispersed geographically, tononetheless maintain the communications network 102 as a secure,private, convenient, and cost-effective resource for the corporation'semployees and/or venders.

At the operation 908, the virus associated with the communicationsnetwork may be determined, the communications network including at leastone of: an Ethernet-based network, a wireless network, a Bluetoothnetwork, a Wi-Fi network, a public switched telephone network, and/or apacket-switched network. For example, as referenced herein, thecommunications network 102 may include a corporate intranet that isprovided as a wireless network across a campus(es) of the corporation.

At the operation 910, the virus associated with the communicationsnetwork may be determined, the communications network including at leastone of: a satellite network, a cellular network, a cable network, afiber network, a microwave network, and/or a paging network. As above,such examples of the communications network 102, and other examples, maybe understood from FIG. 2 and the associated description providedherein, e.g., with reference to the networks 202-212. For example, FIG.2 illustrates the satellite network 210 and/or the satellite radionetwork 212, where the former example may be used, for example, by aninternational corporation or conglomerate (e.g., the user 142) toprovide a high-speed, secure, world-wide corporate network.

FIG. 10 illustrates alternative embodiments of the example operationalflow 400 of FIG. 4. FIG. 10 illustrates example embodiments where thedistributing operation 420 may include at least one additionaloperation. Additional operations may include an operation 1002, anoperation 1004, an operation 1006, an operation 1008, and/or anoperation 1010.

At the operation 1002, the anti-viral agent is determined, based on thevirus. For example, the network monitor 120 of the immunization system110 may implement the detection rules 122 to detect the virus 108 on theinfected network device 116. Then, for example, the response generator126 of the immunization system 110 may determine the anti-viral agent112 (and/or the anti-viral agent 114) in response to the virus 108,e.g., by using the response rules 128 in association with the anti-viralagent data 130.

At the operation 1004, the anti-viral agent may be determined, based onthe virus, wherein the anti-viral agent is configured to prevent and/orinhibit a propagation of the virus onto a network device of thecommunications network, on which the anti-viral agent is loaded. Forexample, the response generator 126 may create, generate, obtain,identify, or otherwise determine the anti-viral agent 112, in responseto certain properties of the virus 108 (e.g., provided by the networkmonitor 120). Then, as described in more detail herein, the responsegenerator 126 may distribute the anti-viral agent 112 onto thecommunications network 102, e.g., onto the non-infected device 118,using the logical bypass network 104. Once present on the non-infecteddevice 118, the anti-viral agent 112 may, for example, immunize thenon-infected device 118 against the virus 108. Therefore, in thisexample, by the time the virus 108 travels from the infected device 116to the non-infected device 118, the multi-network virus immunizationsystem 100 has protected the non-infected device 118 therefrom.

At the operation 1006 the anti-viral agent may be determined as beingconfigured to prevent and/or inhibit a propagation of the virus on thecommunications network. That is, in this example, it may not be the case(as in the operation 1004) that the anti-viral agent 112 is loaded ontoa network device (e.g., the non-infected network device 118) of thecommunications network 102. Rather, for example, it may be the case thatthe immunization system 110 determines the anti-viral agent 112 as onethat simply shuts down communications with the infected network device116, or otherwise prevents or limits propagation of the virus 108 on thecommunications network 102.

At the operation 1008, the anti-viral agent may be provided to a networkdevice of the communications network, wherein the anti-viral agent maybe configured to remove the virus from a network device of thecommunications network. For example, immunization system 110 maydetermine that the virus 108 may have infected a program on the infectednetwork device 116. Then, the immunization system 110 may, for example,provide the anti-viral agent 112 to the infected network device 116, andthe anti-viral agent 112 may be configured to remove the program (andthus the virus 108) from the infected network device 116 of thecommunications network 102.

At the operation 1010, the anti-viral agent may be provided to a networkdevice of the communications network in advance of an infection of thenetwork device by the virus, using the bypass network. For example, theimmunization system 110 may provide the anti-viral agent 112 to thenon-infected network device 118, before the virus 108 reaches thenon-infected network device 118, using, e.g., the logical bypass network104, where, as described herein, the logical bypass network 104 may beconfigured to deliver the anti-viral agent 112 to the non-infectednetwork device 118 with a greater transmission speed than may begenerally available to the virus 108 on the communications network 102.

FIG. 11 illustrates alternative embodiments of the example operationalflow 400 of FIG. 4. FIG. 11 illustrates example embodiments where thedistributing operation 420 may include at least one additionaloperation. Additional operations may include an operation 1102, anoperation 1104, an operation 1106, an operation 1108, and/or anoperation 1110.

At the operation 1102, a reference to the anti-viral agent may beprovided to a network device of the communications network, wherein thereference provides access to the anti-viral agent. For example, theimmunization system 110 may, in response to the virus 108, provide thereference 132 to the communications network 102 rather than theanti-viral agent 112 itself. The reference 132 may include, for example,a key or other access code that allows the non-infected network device118 of the communications network 102 to access the anti-viral agent112, that may be stored, for example, in the anti-viral agent data 130.In an alternative example, the reference may be an internet or intranetaddress that points the non-infected network device 118 of thecommunications network 102 to the anti-viral agent data 130 (which maybe stored offline and/or include a library of anti-viral agent(s)), andthat thereby allows access to the anti-viral agent 112. The referencealso may include instructions or data, such as, for example, a signaturefile, that may be used with a pre-existing anti-viraltechnique/solution/agent to combine to create the anti-viral agent 112.

At the operation 1104, the anti-viral agent may be distributed to thecommunications network including sending a multicast transmission to oneor more network devices of the communications network. For example, theresponse generator 126 may determine that the anti-viral agent 112should be distributed to certain ones of the network devices on thecommunications network 102 (e.g., the network devices having the highestdegree of connectivity to other network devices), and may determine thata multi-cast transmission thereto may provide an effective distributiontechnique for reaching the certain network devices as quickly aspossible in a given circumstance.

At the operation 1106, the anti-viral agent may be distributed to thecommunications network including sending a broadcast transmission to oneor more network devices of the communications network. For example, andin contrast to the example just given, the immunization system 110(e.g., the response generator 126) may determine that a broadcastmessage to all available devices of the communications network 102 maybe the fastest and most effective distribution technique. This may bethe case, for example, in the context of a relatively smaller network,and/or where time is most limited to stop or limit the spread of thevirus 108

At the operation 1108, the anti-viral agent may be distributed onto thecommunications network using the bypass network, wherein the bypassnetwork is at least partially logically separate from the communicationsnetwork. For example, it may be the case that segments or portions ofthe logical bypass network 104 are logically separate from thecommunications network 102, while other segments or portions may becompletely logically separate. Of course, in other implementations, thelogical bypass network 104 may be completely logically separate from thecommunications network 102, as well.

At the operation 1110 the anti-viral agent is distributed onto thecommunications network using the bypass network, wherein the bypassnetwork is associated with an entity-sponsorship thereof. For example,as described herein, the entity 140 may assure, guarantee, provide, orotherwise sponsor the logical bypass network 104 and/or the physicalbypass network 106, so that the user 142 may have a greater reliance on,and enjoyment of, the communications network 102. For example, theentity 140 may sponsor the logical bypass network 104 and/or thephysical bypass network 106 and may assure one or more of the highertransmission speed, the higher transmission reliability, the highertransmission security, and/or the physically-separate transmission path.

FIG. 12 illustrates alternative embodiments of the example operationalflow 400 of FIG. 4. FIG. 12 illustrates example embodiments where thedistributing operation 420 may include at least one additionaloperation. Additional operations may include an operation 1202, anoperation 1204, an operation 1206, and/or an operation 1208.

At the operation 1202 the anti-viral agent may be distributed onto thecommunications network using the bypass network, wherein the bypassnetwork is associated with sponsorship by an entity, the sponsorshipincluding assurance and/or provision of the transmission of theanti-viral agent with the at least one of the higher transmission speed,the higher transmission reliability, the higher transmission security,and/or the physically-separate transmission path. For example, as justdescribed, the entity 140 may provide the logical bypass network 104and/or the physical bypass network 106 having one or more of thecharacteristics of the higher transmission speed, the highertransmission reliability, the higher transmission security, and/or thephysically-separate transmission path.

At the operation 1204, the anti-viral agent may be distributed onto thecommunications network using the bypass network, using a network devicethat is in communications with both the communications network and thebypass network. For example, the immunization system 110 may provide theanti-viral agent 112 to the communications network 102 using the networktraffic manager 136 and the logical bypass network 104, or may providethe anti-viral agent 114 to the communications network 102 using thenetwork traffic manager 138 and the physical bypass network 106.

At the operation 1206 the anti-viral agent may be distributed onto thecommunications network using the bypass network, using a network trafficmanagement device that is operable to implement rules governing thedistributing of the anti-viral agent onto the communications network.For example, and similarly to the example just given, the immunizationsystem 110 may provide the anti-viral agent 112 to the communicationsnetwork 102 using the network traffic manager 136 and the logical bypassnetwork 104, or may provide the anti-viral agent 114 to thecommunications network 102 using the network traffic manager 138 and thephysical bypass network 106. In either or both cases, the networktraffic managers 136, 138 may be operable to implement at least aportion of the immunization system 110, including implementation of theresponse rules 128, which, as described herein, may be used to governwhether, when, and/or how the anti-viral agents 112, 114 may bedistributed onto the communications network 102. Then, for example, thenetwork traffic manager 136 may implement the response rules 128 toprohibit, delay, or impede the transmission of some or allcommunications data on the communications network 102, until theanti-viral agent 112 (or the anti-viral agent 114) has been transmitted.

At the operation 1208, the anti-viral agent may be distributed onto thecommunications network using the bypass network, using a network trafficmanagement device that is operable to prioritize transmission of theanti-viral agent with respect to communications data of thecommunications network. For example, as referenced herein, the networktraffic manager 136 may include a router that is operable to implementtag-prioritized routing, in which the top “n” tags are reserved fortransmitting the anti-viral agent 112.

FIG. 13 illustrates alternative embodiments of the example operationalflow 400 of FIG. 4. FIG. 13 illustrates example embodiments where thedistributing operation 420 may include at least one additionaloperation. Additional operations may include an operation 1302, anoperation 1304, an operation 1306, and/or an operation 1308.

At the operation 1302, the anti-viral agent may be distributed onto thecommunications network using the bypass network, using a network trafficmanagement device that is operable to suppress and/or delay transmissionof the virus relative to transmission of the anti-viral agent. Forexample, the network traffic manager 136 may implement some or all ofthe immunization system 110, and may thus be able to detect or otherwiserecognize the virus 108 (e.g., by detecting a virus signature thereof).Then, the response rules 128 may dictate that any potential virus, suchas the virus 108, should be buffered within the network traffic manager136. In this way, the immunization system 110 may be better able toprovide the anti-viral agent 112 to the communications network 102(e.g., to the non-infected network device 118) in advance of the virus108.

At the operation 1304, the anti-viral agent may be distributed onto thecommunications network using the bypass network, the bypass networkincluding at least one of: a wide area network, a local area network, avirtual local area network, a virtual private network, a metropolitanarea network, a peer-to-peer network, and/or an intranet. For example,as should be apparent from FIG. 3, e.g., from the networks 104, 106,and/or 304-324 (and, by analogy, to the networks 202-212 of FIG. 2), thebypass network 302 may include any number of such examples of networktypes or configurations, as well as many other examples, notspecifically mentioned. For example, the communications network 102 mayinclude a first peer-to-peer network (e.g., the peer-to-peer network208), while the bypass network 302 may include a second peer-to-peernetwork (e.g., the peer-to-peer network(s) 318, 320). In this example,the peer-to-peer networks 208 and 318/320 may be provided in conjunctionwith one another, and may be associated/reserved, respectively, forcommunications data and the anti-viral agent(s) 112, 114.

At the operation 1306, the anti-viral agent may be distributed onto thecommunications network using the bypass network, the bypass networkincluding at least one of: an Ethernet-based network, a wirelessnetwork, a Bluetooth network, a Wi-Fi network, a public switchedtelephone network, and/or a packet-switched network. For example, thebypass network 302 may include the cellular network 316 that isimplemented as a wireless network, and that provides one or more of theherein-described advantages for transmission of the anti-viral agent(s)112, 114 to the communications network 102.

At the operation 1308 the anti-viral agent is distributed onto thecommunications network using the bypass network, the bypass networkincluding at least one of: a satellite network, a satellite radionetwork, a cellular network, a cable network, a fiber network, and/or apaging network. For example, as shown in FIG. 3, the bypass network 302may include the satellite radio network 212. In this case, thecommunications network 102 may include, as referenced herein, aplurality of Bluetooth networks, so that the virus 108 may spread onto amobile phone or PDA as the infected network device 116. Then, asatellite radio transceiver in a vehicle of the user 142 may implementsome or all of the immunization system 110, so that the user 142 mayhave his or her (Bluetooth) mobile phone immunized against the virus 108by way of the satellite radio transceiver. In such examples, the entity140 providing the bypass network 302 (e.g., the satellite radio network212) may include, for example, the operator of the satellite radionetwork 212, or may include a third party associated with, or operatingin partnership with, the satellite radio network operator/provider.

FIG. 14 illustrates alternative embodiments of the example operationalflow 400 of FIG. 4. FIG. 14 illustrates example embodiments where thedistributing operation 420 may include at least one additionaloperation. Additional operations may include an operation 1402, anoperation 1404, an operation 1406, an operation 1408, and/or anoperation 1410.

At the operation 1402, the anti-viral agent may be provided to at leastone network device of the communications network that is ahead of apropagation path of the virus on the communications network. Forexample, as described herein, the immunization system 110 may providethe anti-viral agent 112 to the non-infected network device 118 aheadof, e.g., before, propagation of the virus 108 to the non-infectednetwork device 118 from the infected network device 116.

At the operation 1404, the anti-viral agent may be provided to thecommunications network based on a determination of a potential path ofthe virus, the determination based on a topological analysis of thecommunications network. For example, the communications network 102 mayinclude a network having a mesh, star, tree/hierarchical, bus, or ringtopology, to name a few, and different such topologies may lendthemselves to different distribution techniques (where a determinationbetween distribution techniques may be made, for example, by theresponse generator 126, using the response rules 128). For example, in ahierarchical topology (such as may be used, for example, by a financialinstitution or other hierarchically-arranged corporate structure), theanti-viral agent 112 may be distributed to a certain strategic point onthe tree/hierarchy, so that network devices that are below the strategicpoint are protected from the virus 108, and the strategic point servesas a firebreak for the spread of the virus 108. For example, thenon-infected network device 118 may represent a point on a networkhierarchy having a relatively large number of lower-level devicesconnected thereto. In another example, and as described herein, thecommunications network 102 may include a mesh network, and theimmunization system 110 may select the non-infected network device 118as having a high degree of connectivity to other network devices of thecommunications network 102.

At the operation 1406, the anti-viral agent may be distributed onto thecommunications network using a competitive propagation of the anti-viralagent with respect to the virus. For example, the immunization system110 may determine the anti-viral agent 112 as one that competes with thevirus 108 for resources of the communications network 102 (or networkdevices thereof), so that the anti-viral agent 112 ensures virus 108 is“starved” from propagating in a designed manner. For example, theanti-viral agent may occupy a particular application or feature of thenon-infected network device 118 that is required by the virus 108 forcontinued propagation/replication.

At the operation 1408, the anti-viral agent may be distributed onto thecommunications network based on a determination of a potential path ofthe virus 108, wherein the determination includes a statistical analysisof the determination. For example, the immunization system 110 mayanalyze a current, known distribution of the virus 108, and may combinethis knowledge with general knowledge of the communications network 102(e.g., knowledge of which network device possesses a high degree ofconnectivity) to predict a likely path of the virus 108. Then, forexample, the immunization system 110 may select the network devices withthe highest likelihood of receiving the virus 108, and may prioritizethese network devices for distribution of the anti-viral agent 112thereto.

At the operation 1410 the anti-viral agent may be distributed onto thecommunications network using the bypass network, wherein the bypassnetwork may be configured to provide point-to-point transmission of theanti-viral agent between a first network device and a second networkdevice in less time than the communications network takes to transmitthe virus from the first network device to the second network device.For example, as described herein, the logical bypass network 104 mayinclude some or all of the same physical devices of the communicationsnetwork 102, but may be logically connected in different ways. Thus, thecommunications network 102 may transmit the virus 108 from a firstnetwork device to a second network device in a certain number ofseconds, while the logical bypass network 104 may transmit theanti-viral agent 112 from the first network device to the second networkdevice in some lesser amount of time.

FIG. 15 illustrates alternative embodiments of the example operationalflow 400 of FIG. 4. FIG. 15 illustrates example embodiments where thedistributing operation 420 may include at least one additionaloperation. Additional operations may include an operation 1502, anoperation 1504, and/or an operation 1506.

At the operation 1502 the anti-viral agent may be distributed onto thecommunications network using the bypass network, wherein the bypassnetwork may be configured to provide end-to-end transmission of theanti-viral agent over a network path in less time than thecommunications network takes to transmit the virus over the networkpath. For example, there may be a network path between the infectednetwork device 116 and the non-infected network device 118, and thelogical bypass network 104 may be configured to transmit the anti-viralagent 112 from the infected network device 116 to the non-infectednetwork device 118 in a lesser amount of time than the communicationsnetwork 102, where the network path may include the end-to-endtransmission therebetween, and the end-to-end transmission may include aplurality of point-to-point transmissions between particular, connecteddevices of the communications network 102.

At the operation 1504 the anti-viral agent may be distributed onto thecommunications network using the bypass network, wherein the bypassnetwork may be configured to provide transmission of the anti-viralagent using a bypass transmission medium supporting a higher bandwidththan a communications transmission medium used by the communicationsnetwork. For example, the communications network 102 may include aplurality of network devices connected by Ethernet and may support acertain data throughput, while the physical bypass network 106 maycomprise a plurality of network devices connected by fiber and maysupport some larger data throughput.

At the operation 1506, the anti-viral agent may be distributed onto thecommunications network using the bypass network, wherein the bypassnetwork may be configured to provide transmission of the anti-viralagent using a bypass transmission medium supporting faster data transferthan a communications transmission medium used by the communicationsnetwork. For example, the communications network 102 may include aplurality of network devices connected by Ethernet and may support acertain transmission speed, while the physical bypass network 106 maycomprise a plurality of network devices connected by fiber and maysupport some higher transmission speed.

FIG. 16 illustrates alternative embodiments of the example operationalflow 400 of FIG. 4. FIG. 16 illustrates example embodiments where thedistributing operation 420 may include at least one additionaloperation. Additional operations may include an operation 1602, anoperation 1604, an operation 1606, and/or an operation 1608.

At the operation 1602, the anti-viral agent may be distributed onto thecommunications network using the bypass network, wherein the bypassnetwork is configured to provide a more reliable point-to-pointtransmission of the anti-viral agent between a first network device anda second network device than the communications network. For example,the logical bypass network 104 may include some or all of the samephysical devices of the communications network 102, but may be logicallyconnected in different ways. Thus, the communications network 102 maytransmit the virus 108 from a first network device to a second networkdevice with a certain effective degree of reliability, while the logicalbypass network 104 may transmit the anti-viral agent 112 from the firstnetwork device to the second network device with a relatively greatereffective reliability.

At the operation 1604, the anti-viral agent may be distributed onto thecommunications network using the bypass network, wherein the bypassnetwork may be configured to provide a more reliable end-to-endtransmission of the anti-viral agent between a first network device anda second network device than the communications network. For example,there may be a network path between the infected network device 116 andthe non-infected network device 118, and the logical bypass network 104may be configured to transmit the anti-viral agent 112 from the infectednetwork device 116 to the non-infected network device 118 with a highereffective reliability than the communications network 102, where thenetwork path may include the end-to-end transmission therebetween, andthe end-to-end transmission may include a plurality of point-to-pointtransmissions between particular, connected devices of thecommunications network 102.

At the operation 1606, the anti-viral agent may be distributed onto thecommunications network using the bypass network, wherein the bypassnetwork is configured to provide a transmission of the anti-viral agentwith a greater quality of service (QoS) than the communications network.For example, the immunization system 110 may specifically select thelogical bypass network 104 from a plurality of possible logical bypassnetworks as providing a greater QoS.

At the operation 1608, the anti-viral agent may be distributed onto thecommunications network using the bypass network, wherein the bypassnetwork may be configured to provide a transmission of the anti-viralagent with at least one of: a lesser number of dropped packets, ashorter delay, a lesser likelihood of out-of-order delivery, and/orfewer errors than the communications network. For example, as justdescribed, the immunization system 110 may specifically select thelogical bypass network 104 from a plurality of possible logical bypassnetworks as providing one or more of the above features, or otherfeatures related to an increased effective reliability.

FIG. 17 illustrates alternative embodiments of the example operationalflow 400 of FIG. 4. FIG. 17 illustrates example embodiments where thedistributing operation 420 may include at least one additionaloperation. Additional operations may include an operation 1702, anoperation 1704, and/or an operation 1706.

At the operation 1702, the anti-viral agent may be distributed to thecommunications network using the bypass network, wherein the bypassnetwork may be configured to provide a higher level of data encryptionthan that provided by the communications network. For example, thecommunications network 102 may provide 32-bit data encryption for databeing transferred between a first and a second network device. Then, forexample, the logical bypass network 104 and/or the physical bypassnetwork 106 may provide 64-bit data encryption for data beingtransferred between a first and a second network device.

At the operation 1704, the anti-viral agent may be distributed onto thecommunications network using the bypass network, wherein the bypassnetwork may be configured to provide a more secure point-to-pointtransmission of the anti-viral agent between a first network device anda second network device than the communications network. For example,the logical bypass network 104 may include some or all of the samephysical devices of the communications network 102, but may be logicallyconnected in different ways. Thus, the communications network 102 maytransmit the virus 108 from a first network device to a second networkdevice with a certain effective degree of security, while the logicalbypass network 104 may transmit the anti-viral agent 112 from the firstnetwork device to the second network device with a relatively greatereffective security.

At the operation 1706 the anti-viral agent is distributed onto thecommunications network using the bypass network, wherein the bypassnetwork is configured to provide a more secure end-to-end transmissionof the anti-viral agent between a first network device and a secondnetwork device than the communications network. For example, there maybe a network path between the infected network device 116 and thenon-infected network device 118, and the logical bypass network 104 maybe configured to transmit the anti-viral agent 112 from the infectednetwork device 116 to the non-infected network device 118 with a highereffective security than the communications network 102, where thenetwork path may include the end-to-end transmission therebetween, andthe end-to-end transmission may include a plurality of point-to-pointtransmissions between particular, connected devices of thecommunications network 102.

FIG. 18 illustrates alternative embodiments of the example operationalflow 400 of FIG. 4. FIG. 18 illustrates example embodiments where thedistributing operation 420 may include at least one additionaloperation. Additional operations may include an operation 1802 and/or anoperation 1804.

At the operation 1802, the anti-viral agent may be distributed onto thecommunications network using the bypass network, wherein the bypassnetwork may be configured to provide point-to-point transmission of theanti-viral agent between a first network device and a second networkdevice using a physically-separate path from that used by thecommunications network to transmit the virus from the first networkdevice to the second network device. For example, the communicationsnetwork 102 may transmit the virus 108 point-to-point between twonetwork devices using a first physical path (e.g., a wired path).Meanwhile, the physical bypass network 106 may transmit the anti-viralagent 112 point-to-point between the two network devices using a second,physically-separate path (e.g., a wireless path, perhaps over a cellularnetwork or satellite network).

At the operation 1804, the anti-viral agent may be distributed onto thecommunications network using the bypass network, wherein the bypassnetwork may be configured to provide end-to-end transmission of theanti-viral agent over a physically-separate network path than that usedby the communications network to transmit the virus. For example, theremay be a network path (e.g., a wired network path) between the infectednetwork device 116 and the non-infected network device 118, and thephysical bypass network 106 may be configured to transmit the anti-viralagent 112 from the infected network device 116 to the non-infectednetwork device 118 over a physically separate network path (e.g., awireless network path), where the physically separate network path mayinclude the end-to-end transmission therebetween.

FIG. 19 illustrates a partial view of an example computer programproduct 1900 that includes a computer program 1904 for executing acomputer process on a computing device. An embodiment of the examplecomputer program product 1900 is provided using a signal bearing medium1902, and may include at least one of one or more instructions fordetermining a virus associated with a communications network, and thesignal bearing medium also bearing one or more instructions fordistributing an anti-viral agent onto the communications network using abypass network, the bypass network configured to provide transmission ofthe anti-viral agent with at least one of a higher transmission speed, ahigher transmission reliability, a higher transmission security, and/ora physically-separate transmission path, relative to transmission of thevirus on the communications network. The one or more instructions maybe, for example, computer executable and/or logic-implementedinstructions. In one implementation, the signal-bearing medium 1902 mayinclude a computer-readable medium 1906. In one implementation, thesignal bearing medium 1902 may include a recordable medium 1908. In oneimplementation, the signal bearing medium 1902 may include acommunications medium 1910.

FIG. 20 illustrates an example system 2000 in which embodiments may beimplemented. The system 2000 includes a computing system environment.The system 2000 also illustrates the user 2014 using a device 2004,which is optionally shown as being in communication with a computingdevice 2002 by way of an optional coupling 2006. The optional coupling2006 may represent a local, wide-area, or peer-to-peer network, or mayrepresent a bus that is internal to a computing device (e.g., in exampleembodiments in which the computing device 2002 is contained in whole orin part within the device 2004). A storage medium 2008 may includevirtually any computer storage media.

The computing device 2002 includes computer-executable instructions 2010that when executed on the computing device 2002 cause the computingdevice 2002 to determine a virus associated with a communicationsnetwork, and distribute an anti-viral agent onto the communicationsnetwork using a bypass network, the bypass network configured to providetransmission of the anti-viral agent with at least one of a highertransmission speed, a higher transmission reliability, a highertransmission security, and/or a physically-separate transmission path,relative to transmission of the virus on the communications network.

In FIG. 20, then, the system 2000 includes at least one computing device(e.g., 2002 and/or 2004). The computer-executable instructions 2010 maybe executed on one or more of the at least one computing device. Forexample, the computing device 2002 may implement the computer-executableinstructions 2010 and output a result to (and/or receive data from) thecomputing device 2004. Since the computing device 2002 may be wholly orpartially contained within the computing device 2004, the computingdevice 2004 also may be said to execute some or all of thecomputer-executable instructions 2010, in order to be caused to performor implement, for example, various ones of the techniques describedherein, or other techniques.

The device 2004 may include, for example, one or more of a server, apersonal digital assistant (PDA) or cell phone, a laptop computer, atablet personal computer, a networked computer, a computing systemcomprised of a cluster of processors, a workstation computer, and/or adesktop computer. In another example embodiment, the device 2004 may beoperable to provide the anti-viral agent to the communications networkand prevent, reduce, or inhibit propagation of the virus thereon, usingthe bypass network.

Those having skill in the art will recognize that the state of the arthas progressed to the point where there is little distinction leftbetween hardware and software implementations of aspects of systems; theuse of hardware or software is generally (but not always, in that incertain contexts the choice between hardware and software can becomesignificant) a design choice representing cost vs. efficiency tradeoffs.Those having skill in the art will appreciate that there are variousvehicles by which processes and/or systems and/or other technologiesdescribed herein can be effected (e.g., hardware, software, and/orfirmware), and that the preferred vehicle will vary with the context inwhich the processes and/or systems and/or other technologies aredeployed. For example, if an implementer determines that speed andaccuracy are paramount, the implementer may opt for a mainly hardwareand/or firmware vehicle; alternatively, if flexibility is paramount, theimplementer may opt for a mainly software implementation; or, yet againalternatively, the implementer may opt for some combination of hardware,software, and/or firmware. Hence, there are several possible vehicles bywhich the processes and/or devices and/or other technologies describedherein may be effected, none of which is inherently superior to theother in that any vehicle to be utilized is a choice dependent upon thecontext in which the vehicle will be deployed and the specific concerns(e.g., speed, flexibility, or predictability) of the implementer, any ofwhich may vary. Those skilled in the art will recognize that opticalaspects of implementations will typically employ optically-orientedhardware, software, and or firmware.

The foregoing detailed description has set forth various embodiments ofthe devices and/or processes via the use of block diagrams, flowcharts,and/or examples. Insofar as such block diagrams, flowcharts, and/orexamples contain one or more functions and/or operations, it will beunderstood by those within the art that each function and/or operationwithin such block diagrams, flowcharts, or examples can be implemented,individually and/or collectively, by a wide range of hardware, software,firmware, or virtually any combination thereof. In one embodiment,several portions of the subject matter described herein may beimplemented via Application Specific Integrated Circuits (ASICs), FieldProgrammable Gate Arrays (FPGAs), digital signal processors (DSPs), orother integrated formats. However, those skilled in the art willrecognize that some aspects of the embodiments disclosed herein, inwhole or in part, can be equivalently implemented in integratedcircuits, as one or more computer programs running on one or morecomputers (e.g., as one or more programs running on one or more computersystems), as one or more programs running on one or more processors(e.g., as one or more programs running on one or more microprocessors),as firmware, or as virtually any combination thereof, and that designingthe circuitry and/or writing the code for the software and or firmwarewould be well within the skill of one of skill in the art in light ofthis disclosure. In addition, those skilled in the art will appreciatethat the mechanisms of the subject matter described herein are capableof being distributed as a program product in a variety of forms, andthat an illustrative embodiment of the subject matter described hereinapplies regardless of the particular type of signal bearing medium usedto actually carry out the distribution. Examples of a signal bearingmedium include, but are not limited to, the following: a recordable typemedium such as a floppy disk, a hard disk drive, a Compact Disc (CD), aDigital Video Disk (DVD), a digital tape, a computer memory, etc.; and atransmission type medium such as a digital and/or an analogcommunication medium (e.g., a fiber optic cable, a waveguide, a wiredcommunications link, a wireless communication link, etc.).

In a general sense, those skilled in the art will recognize that thevarious aspects described herein which can be implemented, individuallyand/or collectively, by a wide range of hardware, software, firmware, orany combination thereof can be viewed as being composed of various typesof “electrical circuitry.” Consequently, as used herein “electricalcircuitry” includes, but is not limited to, electrical circuitry havingat least one discrete electrical circuit, electrical circuitry having atleast one integrated circuit, electrical circuitry having at least oneapplication specific integrated circuit, electrical circuitry forming ageneral purpose computing device configured by a computer program (e.g.,a general purpose computer configured by a computer program which atleast partially carries out processes and/or devices described herein,or a microprocessor configured by a computer program which at leastpartially carries out processes and/or devices described herein),electrical circuitry forming a memory device (e.g., forms of randomaccess memory), and/or electrical circuitry forming a communicationsdevice (e.g., a modem, communications switch, or optical-electricalequipment). Those having skill in the art will recognize that thesubject matter described herein may be implemented in an analog ordigital fashion or some combination thereof.

Those skilled in the art will recognize that it is common within the artto describe devices and/or processes in the fashion set forth herein,and thereafter use engineering practices to integrate such describeddevices and/or processes into data processing systems. That is, at leasta portion of the devices and/or processes described herein can beintegrated into a data processing system via a reasonable amount ofexperimentation. Those having skill in the art will recognize that atypical data processing system generally includes one or more of asystem unit housing, a video display device, a memory such as volatileand non-volatile memory, processors such as microprocessors and digitalsignal processors, computational entities such as operating systems,drivers, graphical user interfaces, and applications programs, one ormore interaction devices, such as a touch pad or screen, and/or controlsystems including feedback loops and control motors (e.g., feedback forsensing position and/or velocity; control motors for moving and/oradjusting components and/or quantities). A typical data processingsystem may be implemented utilizing any suitable commercially availablecomponents, such as those typically found in datacomputing/communication and/or network computing/communication systems.

The herein described subject matter sometimes illustrates differentcomponents contained within, or connected with, different othercomponents. It is to be understood that such depicted architectures aremerely exemplary, and that in fact many other architectures can beimplemented which achieve the same functionality. In a conceptual sense,any arrangement of components to achieve the same functionality iseffectively “associated” such that the desired functionality isachieved. Hence, any two components herein combined to achieve aparticular functionality can be seen as “associated with” each othersuch that the desired functionality is achieved, irrespective ofarchitectures or intermediate components. Likewise, any two componentsso associated can also be viewed as being “operably connected,” or“operably coupled,” to each other to achieve the desired functionality.Any two components capable of being so associated can also be viewed asbeing “operably couplable” to each other to achieve the desiredfunctionality. Specific examples of operably couplable include but arenot limited to physically mateable and/or physically interactingcomponents and/or wirelessly interactable and/or wirelessly interactingcomponents and/or logically interacting and/or logically interactablecomponents.

While particular aspects of the present subject matter described hereinhave been shown and described, it will be apparent to those skilled inthe art that, based upon the teachings herein, changes and modificationsmay be made without departing from this subject matter described hereinand its broader aspects and, therefore, the appended claims are toencompass within their scope all such changes and modifications as arewithin the true spirit and scope of this subject matter describedherein. Furthermore, it is to be understood that the invention is solelydefined by the appended claims. It will be understood by those withinthe art that, in general, terms used herein, and especially in theappended claims (e.g., bodies of the appended claims) are generallyintended as “open” terms (e.g., the term “including” should beinterpreted as “including but not limited to,” the term “having” shouldbe interpreted as “having at least,” the term “includes” should beinterpreted as “includes but is not limited to,” etc.). It will befurther understood by those within the art that if a specific number ofan introduced claim recitation is intended, such an intent will beexplicitly recited in the claim, and in the absence of such recitationno such intent is present. For example, as an aid to understanding, thefollowing appended claims may contain usage of the introductory phrases“at least one” and “one or more” to introduce claim recitations.However, the use of such phrases should not be construed to imply thatthe introduction of a claim recitation by the indefinite articles “a” or“an” limits any particular claim containing such introduced claimrecitation to inventions containing only one such recitation, even whenthe same claim includes the introductory phrases “one or more” or “atleast one” and indefinite articles such as “a” or “an” (e.g., “a” and/or“an” should typically be interpreted to mean “at least one” or “one ormore”); the same holds true for the use of definite articles used tointroduce claim recitations. In addition, even if a specific number ofan introduced claim recitation is explicitly recited, those skilled inthe art will recognize that such recitation should typically beinterpreted to mean at least the recited number (e.g., the barerecitation of “two recitations,” without other modifiers, typicallymeans at least two recitations, or two or more recitations).Furthermore, in those instances where a convention analogous to “atleast one of A, B, and C, etc.” is used, in general such a constructionis intended in the sense one having skill in the art would understandthe convention (e.g., “a system having at least one of A, B, and C”would include but not be limited to systems that have A alone, B alone,C alone, A and B together, A and C together, B and C together, and/or A,B, and C together, etc.). In those instances where a conventionanalogous to “at least one of A, B, or C, etc.” is used, in general sucha construction is intended in the sense one having skill in the artwould understand the convention (e.g., “a system having at least one ofA, B, or C” would include but not be limited to systems that have Aalone, B alone, C alone, A and B together, A and C together, B and Ctogether, and/or A, B, and C together, etc.). It will be furtherunderstood by those within the art that any disjunctive word and/orphrase presenting two or more alternative terms, whether in thedescription, claims, or drawings, should be understood to contemplatethe possibilities of including one of the terms, either of the terms, orboth terms. For example, the phrase “A or B” will be understood toinclude the possibilities of “A” or “B” or “A and B.”

What is claimed is:
 1. A system comprising: (a) circuitry fordetermining a virus associated with a communications network; and (b)circuitry for distributing an anti-viral agent on a potentialtransmission path of the virus on the communications network via abypass network, the bypass network configured to provide transmission ofthe anti-viral agent with at least one of higher transmission speed,higher transmission reliability, higher transmission security, or aphysically-separate transmission path relative to transmission of thevirus on the communications network, including at least: (1) circuitryfor distributing the anti-viral agent on the potential transmission pathto a non-infected device of the communications network via the bypassnetwork, the circuitry for distributing being operable to implementrules governing the distributing of the anti-viral agent onto thecommunications network.
 2. The system of claim 1 wherein the circuitryfor determining a virus associated with a communications networkcomprises: circuitry for determining a fault pattern associated with atleast one of the virus or with the communications network; and circuitryfor determining the virus, based at least partially on the faultpattern.
 3. The system of claim 1 wherein the circuitry for determininga virus associated with a communications network comprises: circuitryfor determining the virus associated with the communications network,the communications network including an entity-assured network.
 4. Thesystem of claim 1 wherein the circuitry for determining a virusassociated with a communications network comprises: circuitry fordetermining the virus associated with the communications network, thecommunications network including a subset of a larger network, andprovided in association with the larger network.
 5. The system of claim1 wherein the circuitry for distributing an anti-viral agent on apotential transmission path of the virus on the communications networkvia a bypass network, the bypass network configured to providetransmission of the anti-viral agent with at least one of highertransmission speed, higher transmission reliability, higher transmissionsecurity, or a physically-separate transmission path relative totransmission of the virus on the communications network comprises:circuitry for providing the anti-viral agent to a non-infected device ofthe communications network in advance of the virus reaching thenon-infected device, using the bypass network.
 6. The system of claim 1wherein the circuitry for distributing an anti-viral agent on apotential transmission path of the virus on the communications networkvia a bypass network, the bypass network configured to providetransmission of the anti-viral agent with at least one of highertransmission speed, higher transmission reliability, higher transmissionsecurity, or a physically-separate transmission path relative totransmission of the virus on the communications network comprises:circuitry for providing a reference to the anti-viral agent to anon-infected device of the communications network, wherein the referenceprovides access to the anti-viral agent and wherein the referenceincludes at least other than the anti-viral agent itself.
 7. The systemof claim 1 wherein the circuitry for distributing an anti-viral agent ona potential transmission path of the virus on the communications networkvia a bypass network, the bypass network configured to providetransmission of the anti-viral agent with at least one of highertransmission speed, higher transmission reliability, higher transmissionsecurity, or a physically-separate transmission path relative totransmission of the virus on the communications network comprises:circuitry for distributing the anti-viral agent on the potentialtransmission path to a non-infected device of the communications networkvia the bypass network, wherein the bypass network is at least partiallylogically separate from the communications network.
 8. The system ofclaim 1 wherein the circuitry for distributing an anti-viral agent on apotential transmission path of the virus on the communications networkvia a bypass network, the bypass network configured to providetransmission of the anti-viral agent with at least one of highertransmission speed, higher transmission reliability, higher transmissionsecurity, or a physically-separate transmission path relative totransmission of the virus on the communications network comprises:circuitry for distributing the anti-viral agent on the potentialtransmission path to a non-infected device of the communications networkvia the bypass network, wherein the bypass network is associated with anentity sponsorship thereof.
 9. The system of claim 1 wherein thecircuitry for distributing an anti-viral agent on a potentialtransmission path of the virus on the communications network via abypass network, the bypass network configured to provide transmission ofthe anti-viral agent with at least one of higher transmission speed,higher transmission reliability, higher transmission security, or aphysically-separate transmission path relative to transmission of thevirus on the communications network comprises: circuitry fordistributing the anti-viral agent on the potential transmission path toa non-infected device of the communications network via the bypassnetwork, wherein the bypass network is associated with sponsorship by anentity, the sponsorship including at least one of assurance or provisionof the transmission of the anti-viral agent with the at least one ofhigher transmission speed, higher transmission reliability, highertransmission security, or a physically-separate transmission path. 10.The system of claim 1 wherein the circuitry for distributing ananti-viral agent on a potential transmission path of the virus on thecommunications network via a bypass network, the bypass networkconfigured to provide transmission of the anti-viral agent with at leastone of higher transmission speed, higher transmission reliability,higher transmission security, or a physically-separate transmission pathrelative to transmission of the virus on the communications networkcomprises: circuitry for distributing the anti-viral agent on thepotential transmission path to a non-infected device of thecommunications network via the bypass network, wherein the non-infecteddevice is configured to be in communications with both thecommunications network and the bypass network.
 11. The system of claim 1wherein the circuitry for distributing an anti-viral agent on apotential transmission path of the virus on the communications networkvia a bypass network, the bypass network configured to providetransmission of the anti-viral agent with at least one of highertransmission speed, higher transmission reliability, higher transmissionsecurity, or a physically-separate transmission path relative totransmission of the virus on the communications network comprises:circuitry for distributing the anti-viral agent on the potentialtransmission path to a non-infected device of the communications networkvia the bypass network, using a network traffic management device thatis operable to prioritize transmission of the anti-viral agent withrespect to communications data of the communications network.
 12. Thesystem of claim 1 wherein the circuitry for distributing an anti-viralagent on a potential transmission path of the virus on thecommunications network via a bypass network, the bypass networkconfigured to provide transmission of the anti-viral agent with at leastone of higher transmission speed, higher transmission reliability,higher transmission security, or a physically-separate transmission pathrelative to transmission of the virus on the communications networkcomprises: circuitry for distributing the anti-viral agent on thepotential transmission path to a non-infected device of thecommunications network via the bypass network, using a network trafficmanagement device that is operable to at least one of suppress or delaytransmission of the virus relative to transmission of the anti-viralagent.
 13. The system of claim 1 wherein the circuitry for distributingan anti-viral agent on a potential transmission path of the virus on thecommunications network via a bypass network, the bypass networkconfigured to provide transmission of the anti-viral agent with at leastone of higher transmission speed, higher transmission reliability,higher transmission security, or a physically-separate transmission pathrelative to transmission of the virus on the communications networkcomprises: circuitry for distributing the anti-viral agent on thepotential transmission path to a non-infected device of thecommunications network via the bypass network, the bypass networkincluding at least one of: a virtual local area network, a virtualprivate network, a peer-to-peer network, or an intranet.
 14. The systemof claim 1 wherein the circuitry for distributing an anti-viral agent ona potential transmission path of the virus on the communications networkvia a bypass network, the bypass network configured to providetransmission of the anti-viral agent with at least one of highertransmission speed, higher transmission reliability, higher transmissionsecurity, or a physically-separate transmission path relative totransmission of the virus on the communications network comprises:circuitry for distributing the anti-viral agent on the potentialtransmission path to a non-infected device of the communications networkvia the bypass network, the bypass network including at least one of: asatellite network, a satellite radio network, a cellular network, or apaging network.
 15. The system of claim 1 wherein the circuitry fordistributing an anti-viral agent on a potential transmission path of thevirus on the communications network via a bypass network, the bypassnetwork configured to provide transmission of the anti-viral agent withat least one of higher transmission speed, higher transmissionreliability, higher transmission security, or a physically-separatetransmission path relative to transmission of the virus on thecommunications network comprises: circuitry for providing the anti-viralagent on the potential transmission path to a non-infected device aheadof a propagation path of the virus on the communications network to thenon-infected device.
 16. The system of claim 1 wherein the circuitry fordistributing an anti-viral agent on a potential transmission path of thevirus on the communications network via a bypass network, the bypassnetwork configured to provide transmission of the anti-viral agent withat least one of higher transmission speed, higher transmissionreliability, higher transmission security, or a physically-separatetransmission path relative to transmission of the virus on thecommunications network comprises: circuitry for distributing ananti-viral agent on a potential transmission path of the virus on thecommunications network via a bypass network, the bypass networkconfigured to provide transmission of the anti-viral agent with at leastone higher transmission security, relative to transmission of the viruson the communications network, wherein the distributing includes atleast providing the anti-viral agent on the potential transmission pathof the virus on the communications network based on a determination ofthe potential transmission path of the virus, the determination based atleast partially on a pre-existing knowledge of the communicationsnetwork.
 17. The system of claim 1 wherein the circuitry fordistributing an anti-viral agent on a potential transmission path of thevirus on the communications network via a bypass network, the bypassnetwork configured to provide transmission of the anti-viral agent withat least one of higher transmission speed, higher transmissionreliability, higher transmission security, or a physically-separatetransmission path relative to transmission of the virus on thecommunications network comprises: circuitry for distributing theanti-viral agent on the potential transmission path to a non-infecteddevice of the communications network via the bypass network, the bypassnetwork configured to provide transmission of the anti-viral agent withat least one higher transmission reliability, wherein the bypass networkis configured to provide a more reliable point-to-point transmission ofthe anti-viral agent to the non-infected device than the communicationsnetwork.
 18. The system of claim 1 wherein the circuitry fordistributing an anti-viral agent on a potential transmission path of thevirus on the communications network via a bypass network, the bypassnetwork configured to provide transmission of the anti-viral agent withat least one of higher transmission speed, higher transmissionreliability, higher transmission security, or a physically-separatetransmission path relative to transmission of the virus on thecommunications network comprises: circuitry for distributing theanti-viral agent on the potential transmission path to a non-infecteddevice of the communications network via the bypass network, the bypassnetwork configured to provide transmission of the anti-viral agent withat least one higher transmission reliability wherein the bypass networkis configured to provide a more reliable end-to-end transmission of theanti-viral agent to the non-infected device than the communicationsnetwork.
 19. The system of claim 1 wherein the circuitry fordistributing an anti-viral agent on a potential transmission path of thevirus on the communications network via a bypass network, the bypassnetwork configured to provide transmission of the anti-viral agent withat least one of higher transmission speed, higher transmissionreliability, higher transmission security, or a physically-separatetransmission path relative to transmission of the virus on thecommunications network comprises: circuitry for distributing theanti-viral agent on the potential transmission path to a non-infecteddevice of the communications network via the bypass network, wherein thebypass network is configured to provide a transmission of the anti-viralagent to the non-infected device with a greater quality of service (QoS)than the communications network.
 20. The system of claim 1 wherein thecircuitry for distributing an anti-viral agent on a potentialtransmission path of the virus on the communications network via abypass network, the bypass network configured to provide transmission ofthe anti-viral agent with at least one of higher transmission speed,higher transmission reliability, higher transmission security, or aphysically-separate transmission path relative to transmission of thevirus on the communications network comprises: circuitry fordistributing the anti-viral agent on the potential transmission path toa non-infected device of the communications network via the bypassnetwork, wherein the bypass network is configured to provide atransmission of the anti-viral agent to the non-infected device with atleast one of: a lesser number of dropped packets, a shorter delay, alesser likelihood of out-of-order delivery, or fewer errors than thecommunications network.
 21. The system of claim 1 wherein the circuitryfor distributing an anti-viral agent on a potential transmission path ofthe virus on the communications network via a bypass network, the bypassnetwork configured to provide transmission of the anti-viral agent withat least one of higher transmission speed, higher transmissionreliability, higher transmission security, or a physically-separatetransmission path relative to transmission of the virus on thecommunications network comprises: circuitry for distributing theanti-viral agent on the potential transmission path to a non-infecteddevice of the communications network via the bypass network, wherein thebypass network is configured to provide a higher level of dataencryption to the non-infected device than that provided by thecommunications network.
 22. The system of claim 1 wherein the circuitryfor distributing an anti-viral agent on a potential transmission path ofthe virus on the communications network via a bypass network, the bypassnetwork configured to provide transmission of the anti-viral agent withat least one of higher transmission speed, higher transmissionreliability, higher transmission security, or a physically-separatetransmission path relative to transmission of the virus on thecommunications network comprises: circuitry for distributing theanti-viral agent on the potential transmission path to a non-infecteddevice of the communications network via the bypass network, wherein thebypass network is configured to provide a more secure point-to-pointtransmission of the anti-viral agent to the non-infected device than thecommunications network.
 23. The system of claim 1 wherein the circuitryfor distributing an anti-viral agent on a potential transmission path ofthe virus on the communications network via a bypass network, the bypassnetwork configured to provide transmission of the anti-viral agent withat least one of higher transmission speed, higher transmissionreliability, higher transmission security, or a physically-separatetransmission path relative to transmission of the virus on thecommunications network comprises: circuitry for distributing theanti-viral agent on the potential transmission path to a non-infecteddevice of the communications network via the bypass network, wherein thebypass network is configured to provide a more secure end-to-endtransmission of the anti-viral agent to the non-infected device than thecommunications network.
 24. The system of claim 1 wherein the circuitryfor distributing an anti-viral agent on a potential transmission path ofthe virus on the communications network via a bypass network, the bypassnetwork configured to provide transmission of the anti-viral agent withat least one of higher transmission speed, higher transmissionreliability, higher transmission security, or a physically-separatetransmission path relative to transmission of the virus on thecommunications network comprises: circuitry for distributing theanti-viral agent on the potential transmission path to a non-infecteddevice of the communications network via the bypass network, wherein thebypass network is configured to provide point-to-point transmission ofthe anti-viral agent to the non-infected device using aphysically-separate path from that used by the communications network totransmit the virus to the non-infected device.
 25. The system of claim 1wherein the circuitry for distributing an anti-viral agent on apotential transmission path of the virus on the communications networkvia a bypass network, the bypass network configured to providetransmission of the anti-viral agent with at least one of highertransmission speed, higher transmission reliability, higher transmissionsecurity, or a physically-separate transmission path relative totransmission of the virus on the communications network comprises:circuitry for distributing the anti-viral agent on the potentialtransmission path to a non-infected device of the communications networkvia the bypass network, wherein the bypass network is configured toprovide end-to-end transmission of the anti-viral agent to thenon-infected device over a physically-separate network path than thatused by the communications network to transmit the virus to thenon-infected device.
 26. The system of claim 1 wherein the circuitry fordistributing the anti-viral agent on the potential transmission path toa non-infected device of the communications network via the bypassnetwork, the circuitry for distributing being operable to implementrules governing the distributing of the anti-viral agent onto thecommunications network comprises: circuitry for implementing rules forat least buffering at least some of the virus until at least some of theanti-virus agent is distributed onto the communications network.
 27. Thesystem of claim 1 wherein the circuitry for distributing the anti-viralagent on the potential transmission path to a non-infected device of thecommunications network via the bypass network, the circuitry fordistributing being operable to implement rules governing thedistributing of the anti-viral agent onto the communications networkcomprises: circuitry for implementing rules for at least one ofprohibiting, delaying, suppressing, or impeding transmission of at leastsome communications data on the communications network until at leastsome of the anti-virus agent is distributed onto the communicationsnetwork.
 28. The system of claim 1 wherein the circuitry fordistributing the anti-viral agent on the potential transmission path toa non-infected device of the communications network via the bypassnetwork, the circuitry for distributing being operable to implementrules governing the distributing of the anti-viral agent onto thecommunications network comprises: circuitry for implementing rules fordistributing the anti-viral agent onto the communications network atleast in part by at least one of starving the virus of at least someresources, depriving the virus of at least some resources, or competingwith the virus for at least some resources.
 29. The system of claim 1wherein the circuitry for distributing the anti-viral agent on thepotential transmission path to a non-infected device of thecommunications network via the bypass network, the circuitry fordistributing being operable to implement rules governing thedistributing of the anti-viral agent onto the communications networkcomprises: circuitry for implementing rules for selecting at least onedistribution strategy from two or more distribution strategies fordistributing the anti-viral agent on the communications networkresponsive at least in part to the circuitry for determining a virusassociated with a communications network.
 30. The system of claim 1wherein the circuitry for distributing the anti-viral agent on thepotential transmission path to a non-infected device of thecommunications network via the bypass network, the circuitry fordistributing being operable to implement rules governing thedistributing of the anti-viral agent onto the communications networkcomprises: circuitry for implementing rules for at least one of creatingor selecting an anti-viral agent for distribution responsive at least inpart to the circuitry for determining a virus associated with acommunications network.
 31. The system of claim 1 wherein the circuitryfor distributing the anti-viral agent on the potential transmission pathto a non-infected device of the communications network via the bypassnetwork, the circuitry for distributing being operable to implementrules governing the distributing of the anti-viral agent onto thecommunications network comprises: circuitry for implementing rules forat least determining at least one of a location or a procedure forinjecting the anti-viral agent onto the communications network.
 32. Thesystem of claim 1 wherein the circuitry for distributing the anti-viralagent on the potential transmission path to a non-infected device of thecommunications network via the bypass network, the circuitry fordistributing being operable to implement rules governing thedistributing of the anti-viral agent onto the communications networkcomprises: circuitry for implementing rules for at least determining atleast a path for distribution of the anti-viral agent.
 33. The system ofclaim 32 wherein the circuitry for implementing rules for at leastdetermining at least a path for distribution of an anti-viral agentcomprises: circuitry for selecting at least one of a physically-separatebypass network or a logically-separate bypass network for distributionof the anti-viral agent onto the communications network.
 34. A systemcomprising: (a) a determination module configured for determining avirus associated with a communications network; and (b) a distributionmodule configured for distributing an anti-viral agent on a potentialtransmission path of the virus on the communications network via abypass network, the bypass network configured to provide transmission ofthe anti-viral agent with at least one of higher transmission speed,higher transmission reliability, higher transmission security, or aphysically-separate transmission path relative to transmission of thevirus on the communications network, including at least: (1) adistribution module configured for distributing the anti-viral agent onthe potential transmission path to a non-infected device of thecommunications network via the bypass network, at least in part using anetwork traffic management device that is operable to implement rulesgoverning the distributing of the anti-viral agent onto thecommunications network.
 35. A method comprising: (a) determining a virusassociated with a communications network; and (b) distributing ananti-viral agent on a potential transmission path of the virus on thecommunications network via a bypass network, the bypass networkconfigured to provide transmission of the anti-viral agent with at leastone of higher transmission speed, higher transmission reliability,higher transmission security, or a physically-separate transmission pathrelative to transmission of the virus on the communications network,including at least: (1) distributing the anti-viral agent on thepotential transmission path to a non-infected device of thecommunications network via the bypass network, at least in part using anetwork traffic management device that is operable to implement rulesgoverning the distributing of the anti-viral agent onto thecommunications network.